<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0191452</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-35905</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Gene regulation</subject><subj-group><subject>MicroRNAs</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>RNA</subject><subj-group><subject>Non-coding RNA</subject><subj-group><subject>MicroRNAs</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>DNA-binding proteins</subject><subj-group><subject>Transcription factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Gene regulation</subject><subj-group><subject>Transcription factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Regulatory proteins</subject><subj-group><subject>Transcription factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject><subj-group><subject>Inner ear</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject><subj-group><subject>Inner ear</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Gene regulation</subject><subj-group><subject>Transcriptional control</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Cell signaling</subject><subj-group><subject>Developmental signaling</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Computational biology</subject><subj-group><subject>Genome analysis</subject><subj-group><subject>Gene ontologies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome analysis</subject><subj-group><subject>Gene ontologies</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Gene regulation</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Developmental profiling of microRNAs in the human embryonic inner ear</article-title>
<alt-title alt-title-type="running-head">MicroRNAs in the human embryonic inner ear</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Chadly</surname>
<given-names>Duncan M.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Best</surname>
<given-names>Jennifer</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Ran</surname>
<given-names>Cong</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bruska</surname>
<given-names>Małgorzata</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="fn" rid="econtrib001"><sup>‡</sup></xref>
</contrib>
<contrib contrib-type="author" deceased="yes" xlink:type="simple">
<name name-style="western">
<surname>Woźniak</surname>
<given-names>Witold</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kempisty</surname>
<given-names>Bartosz</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Schwartz</surname>
<given-names>Mark</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>LaFleur</surname>
<given-names>Bonnie</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="fn" rid="econtrib001"><sup>‡</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kerns</surname>
<given-names>B. J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Kessler</surname>
<given-names>John A.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1066-6514</contrib-id>
<name name-style="western">
<surname>Matsuoka</surname>
<given-names>Akihiro J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Otolaryngology and Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Anatomy, Poznań University, Poznań, Poland</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>HTG Molecular Diagnostics, Inc., Tucson, Arizona, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, United States of America</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Hugh Knowles Center for Hearing Research, Northwestern University, Evanston, Illinois, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>van Wijnen</surname>
<given-names>Andre</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Massachusetts Medical School, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>We have read the journal's policy and the authors of the manuscript have the following competing interests: MS, BL, and BJK are employees of HTG Molecular Diagnostics, Inc., which has developed HTG Edgeseq miRNA whole transcriptome assay used in this study. HTG Molecular Diagnostics, Inc. does not alter our adherence to PLOS ONE policies on sharing data and materials.</p>
</fn>
<fn fn-type="other" id="econtrib001">
<p>‡ These authors also contributed equally to this work.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">amatsuoka@nm.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<elocation-id>e0191452</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Chadly et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0191452"/>
<abstract>
<p>Due to the extreme inaccessibility of fetal human inner ear tissue, defining of the microRNAs (miRNAs) that regulate development of the inner ear has relied on animal tissue. In the present study, we performed the first miRNA sequencing of otic precursors in human specimens. Using HTG miRNA Whole Transcriptome assays, we examined miRNA expression in the cochleovestibular ganglion (CVG), neural crest (NC), and otic vesicle (OV) from paraffin embedded (FFPE) human specimens in the Carnegie developmental stages 13–15. We found that in human embryonic tissues, there are different patterns of miRNA expression in the CVG, NC and OV. In particular, members of the miR-183 family (miR-96, miR-182, and miR-183) are differentially expressed in the CVG compared to NC and OV at Carnegie developmental stage 13. We further identified transcription factors that are differentially targeted in the CVG compared to the other tissues from stages 13–15, and we performed gene set enrichment analyses to determine differentially regulated pathways that are relevant to CVG development in humans. These findings not only provide insight into the mechanisms governing the development of the human inner ear, but also identify potential signaling pathways for promoting regeneration of the spiral ganglion and other components of the inner ear.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>The Eleanor Wood-Price Grants Initiative: The Woman’s Board of Northwestern Memorial Hospital</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1066-6514</contrib-id>
<name name-style="western">
<surname>Matsuoka</surname>
<given-names>Akihiro J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>The Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1066-6514</contrib-id>
<name name-style="western">
<surname>Matsuoka</surname>
<given-names>Akihiro J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by the Eleanor Wood-Price Grants Initiative: The Woman’s Board of Northwestern Memorial Hospital [AJM] and the Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University [AJM]. HTG Molecular Diagnostics, Inc. provided support in the form of salaries for authors MS, BL, and BJK. MS had a role in Methodology and Investigation (performed HTG Edgeseq miRNA whole transcriptome assay), BL had a role in Software (wrote initial R code for our differential expression analysis), and BJK had a role in Project Administration. The specific roles of these authors are also articulated in the ‘author contributions’ section.</funding-statement>
</funding-group>
<counts>
<fig-count count="8"/>
<table-count count="5"/>
<page-count count="27"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data can be found in Supporting Information files. Sequencing data is available from NCBI GEO (GSE109137).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>MicroRNAs (miRNA) are a class of endogenously expressed small non-coding RNAs that function in RNA silencing and post-transcriptional regulation of gene expression. The human genome encodes more than 1000 miRNAs that may target as many as 60% of human protein-encoding genes [<xref ref-type="bibr" rid="pone.0191452.ref001">1</xref>]. miRNAs regulate stem/progenitor cell proliferation and differentiation as well as organ development and function [<xref ref-type="bibr" rid="pone.0191452.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0191452.ref002">2</xref>], and more specifically they have been shown to be involved in mouse inner ear development and maturation [<xref ref-type="bibr" rid="pone.0191452.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0191452.ref004">4</xref>]. Disruption of the production of miRNAs causes profound inner ear malformation and deafness [<xref ref-type="bibr" rid="pone.0191452.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0191452.ref008">8</xref>], and a mutation in a single miRNA, miR-96, causes deafness in both humans and mice [<xref ref-type="bibr" rid="pone.0191452.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0191452.ref010">10</xref>]. In addition, the miR-183 family (miR-96, miR-182, and miR-183) is differentially expressed in the mouse inner ear as compared to other organs [<xref ref-type="bibr" rid="pone.0191452.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0191452.ref011">11</xref>]. However, little is known about miRNA expression in human inner ear development.</p>
<p>The HTG EdgeSeq System (HTG Molecular Diagnostics, Tucson, AZ, USA) is an automated miRNA expression analysis platform that can deliver reliable results on a previously generated histopathology slide (i.e., a formalin-fixed paraffin-embedded (FFPE) slide) [<xref ref-type="bibr" rid="pone.0191452.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0191452.ref015">15</xref>]. This technique is used here to define the miRNA expression profile in otic precursors in human FFPE specimens at Carnegie developmental stages 13–15 (corresponding to 32 to 35 postovulatory days) [<xref ref-type="bibr" rid="pone.0191452.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0191452.ref017">17</xref>]. We demonstrated in human embryonic tissues that members of the miR-183 family are differentially expressed in the cochleovestibular ganglion (CVG) at embryonic stage 13 in the human inner ear as compared to nearby neural crest (NC) and otic vesicle (OV) tissues. We further identified transcription factors that are differentially targeted in the CVG compared to the other tissues from stages 13–15, and performed gene set enrichment analyses to determine differentially regulated signaling pathways, many of which are relevant to CVG development in humans.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec003">
<title>Sample collection</title>
<p>Three FFPE human embryo specimens were provided by Dr. Malgorzata Bruska in the Department of Anatomy, Poznań University, Poland. These slides had been used previously for educational purpose at Poznań University. The slides were labeled (<xref ref-type="fig" rid="pone.0191452.g001">Fig 1A</xref>) as follows: 1) B218—embryo at the Carnegie stage 13, 32 post ovulatory days; 2) AS21—embryo at the Carnegie stage 14, 33 post ovulatory days; 3) PJK20—embryo at the Carnegie stage 15, 35 post ovulatory days. Carnegie developmental stages 13, 14, and 15 in human development correspond to embryonic days 11 (E11), E11.5, and E12, respectively in mouse. Each FFPE slide was placed in a small Coplin jar in fresh xylene to remove the cover slip. The xylene solution was changed every 72 hours. Each cover slip was removed from the slide within 1 week without difficulties. We chose three areas of interest, the CVG, NC, and OV, because we are interested in miRNA expression during CVG development as compared to NC or OV tissues. Note that CVG consists of both the spiral (auditory) and vestibular ganglions and thus includes the developmental precursors of spiral ganglion neurons (SGNs) [<xref ref-type="bibr" rid="pone.0191452.ref018">18</xref>]. The three areas were dissected using a Zeiss Palm laser catapulting micro-dissection system and collected in CZMI Adhesive Cap 500 collection tubes (Carl Zeiss, Oberkochen, Germany). An example of the dissection of the CVG and NC area is provided in <xref ref-type="fig" rid="pone.0191452.g001">Fig 1B–1F</xref>. Samples were provided as formalin-fixed, paraffin-embedded, hematoxylin and eosin stained tissue. Profiles were collected for three tissue types (CVG, NC, and OV) at three developmental time points (Carnegie developmental stage 13, 14, and 15, corresponding to 33, 34, and 35 postovulatory days) with three technical replicates. Each Adhesive Cap collection tube contained approximately 5 cross-sectional slices of the area of interest. The samples were labeled as described in <xref ref-type="supplementary-material" rid="pone.0191452.s001">S1 Table</xref>.</p>
<fig id="pone.0191452.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Laser-microdissection of FFPE-human inner ear slides.</title>
<p>(A) FFPE slides containing embryonic tissues. (B) Coronal section of a fetus with highlighted regions of interest (dashed black circles, CVG, NC, and OV). Further images are provided showing tissue before (C, E) and after (D, F) laser-captured microdissection of CVG (dashed white lines in D) and NC tissues (dashed white line in F). Other developmental regions also are highlighted. CVG: cochlear-vestibular ganglions, OV: otic vesicle, NC: neural crest; GG: geniculate ganglion, G-CVG: geniculate-cochleovestibular ganglions, E: epithelium; and NT: neural tube. Scale bar = 100 μm (B) and 150 μm (C-F).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec004">
<title>HTG Edgeseq miRNA whole transcriptome assay (WTA)</title>
<p>HTG Edgeseq miRNA whole transcriptome assay (WTA) is a next-generation sequencing (NGS) application that measures the expression of 2,255 human miRNAs described in the miRBase v20 database without the need for extracting RNA [<xref ref-type="bibr" rid="pone.0191452.ref019">19</xref>]. Lysis of collected cells in each tube was performed by applying 55μL of HTG Lysis Buffer (HTG Molecular, Tucson, AZ) to the cap and incubating upside down for 30 minutes at room temperature. After 30 minutes the sample was spun down and 2.8μL of Proteinase K (HTG Molecular, Tucson, AZ, USA) was added, and the sample was then incubated for 180 minutes at 50°C. From each prepared sample, 25μL were added per well to a 96-well sample plate. Human fetal Brain RNA was added to one well at 25 ng/well to serve as a process control. Samples were run on an HTG EdgeSeq Processor using the HTG EdgeSeq miRNA WTA (HTG Molecular, Tucson, AZ, USA). This assay revolves around nuclease protection, where a pre-selected miRNA population is protected with proprietary protection probes, followed by degradation of all nonhybridized probes and non-targeted RNA by S1 nuclease. This step results in a 1:1 stoichiometric ratio of probes to targeted RNA. Following the processor step, samples were individually barcoded (using a 16-cycle PCR reaction to add adapters and molecular barcodes). Barcoded samples were individually purified using AMPure XP beads (Beckman Coulter, Brea, CA, USA) and quantitated using a KAPA Library Quantification kit (KAPA Biosystem, Wilmington, MA, USA). The library was sequenced on an Illumina MiSeq (Illumina, Inc., San Diego, CA) using a V3 150-cycle kit with two index reads. PhiX was spiked into the library at 5%; this spike-in control is standard for Illumina sequencing libraries. Data were returned from the sequencer in the form of demultiplexed FASTQ files, with one file per original well of the assay. The HTG EdgeSeq Parser (HTG Molecular, Tucson, AZ, USA) was used to align the FASTQ files to the probe list to collate the data. Data were provided as data tables of raw, quality control (QC) raw, counts per million (CPM), and median normalized counts.</p>
</sec>
<sec id="sec005">
<title>Quality control</title>
<p>Baseline performance characteristics were established using Human Universal Reference RNA (uRNA) (Agilent genomics, Santa Clara, CA, USA) across all 96 wells on three sequencing runs of 96-well, with each plate processed on a different HTG EdgeSeq processor. Log<sub>2</sub> counts per million (log<sub>2</sub>(CPM)) standardization was used to transformed counts and adjusted for total reads within a sample [<xref ref-type="bibr" rid="pone.0191452.ref020">20</xref>]. The RNA-sequence data consist of a matrix of read count <italic>r</italic><sub><italic>gi</italic></sub>, for RNA samples <italic>i</italic> = 1 to <italic>n</italic>, and genes <italic>g</italic> = 1 to <italic>G</italic>. <italic>Ri</italic>, the total number of mapped reads for sample <italic>I</italic>, is defined as:
<disp-formula id="pone.0191452.e001">
<alternatives>
<graphic id="pone.0191452.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0191452.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mi>R</mml:mi><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:munderover></mml:mstyle><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
The log<sub>2</sub>(CPM) values for each probe within a sample was defined as:
<disp-formula id="pone.0191452.e002">
<alternatives>
<graphic id="pone.0191452.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0191452.e002" xlink:type="simple"/>
<mml:math display="block" id="M2">
<mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>0.5</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1.0</mml:mn></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
Where <italic>y</italic><sub><italic>gi</italic></sub> is normalized count for sample <italic>i</italic> and gene <italic>g</italic>. The counts are offset by 0.5 to avoid taking the log of zero, and total counts are offset by 1 to ensure the ratio is strictly less than 1 [<xref ref-type="bibr" rid="pone.0191452.ref020">20</xref>].</p>
<p>Baseline performance was established on the 96 technical replicates after normalization. Statistical process control methods were used to establish this expected performance where averaged ANT values (negative control) were calculated for each sample; a grand mean was calculated by taking the average of these averaged ANT values; the difference between each averaged ANT value and the grand mean, Δmean (averaged sample mean–grand mean) and standard deviation (SD) of the Δmean was calculated was for each sample. Acceptable Δmean values are those within ± 2SD average ANT. The graphical representation of the statistical process control, the quality control chart, for ANT using 96 miRNA technical replicates is shown in <xref ref-type="supplementary-material" rid="pone.0191452.s002">S1 Fig</xref>.</p>
</sec>
<sec id="sec006">
<title>miRNA differential expression analysis and principal components analysis</title>
<p>A median normalization was used to transform and standardize data before data analyses [<xref ref-type="bibr" rid="pone.0191452.ref021">21</xref>]. The primary statistical analysis was performed within the three time points and examined the differences in the pattern of expression among CVG, NC, and OV cell types. The R Bioconductor package (version 3.5) Linear Models for Microarray and RNA-Seq Data (<italic>limma</italic>) was used for the statistical analyses [<xref ref-type="bibr" rid="pone.0191452.ref022">22</xref>]. Secondary statistical analysis examined differences in the pattern of expression over time within the CVG, NC, and OV cell types. The R Bioconductor package (version 3.5) time course was used for this analysis [<xref ref-type="bibr" rid="pone.0191452.ref023">23</xref>]. The top 100 differentially expressed miRNA molecules across time points, ranked by significance (Hotelling’s t-squared statistic), were determined for each of the three tissues. The maximal test statistic for the comparisons across three time points (stage 13 vs. 14, 14 vs. 15, and 13 vs. 15) was tabulated; differentially expressed miRNAs, indicating potential developmental relevance, were then identified by comparing these lists. Differential expression analyses included a correction for false discovery rate (FDR) was performed using the Benjamini-Hochberg Method [<xref ref-type="bibr" rid="pone.0191452.ref024">24</xref>]. The R Bioconductor (version 3.5) was used for the analysis [<xref ref-type="bibr" rid="pone.0191452.ref025">25</xref>]. To understand the primary determinant of miRNA expression and to examine sample clustering, Principal Component Analysis (PCA) was performed to identify the drivers of differences. Normalized miRNA expression values were assembled into a matrix with rows of different sample types and columns of miRNAs.</p>
</sec>
<sec id="sec007">
<title>Over-connected gene analysis</title>
<p>Hypergeometric enrichment was used to identify genes significantly over-connected to miRNAs detected in our differential expression datasets. Gene targets of miRNA were predicted by combining the TargetScan (version 7.1) nonconserved and conserved family databases, using all predicted targets for the human species [<xref ref-type="bibr" rid="pone.0191452.ref026">26</xref>]. This provided targets for 1408 of the miRNA families that were used for over-connected gene analysis. A list was compiled of all miRNA-gene links, allowing for multiple targets per miRNA. The hypergeometric distribution was used to compute <italic>p</italic>-values:
<disp-formula id="pone.0191452.e003">
<alternatives>
<graphic id="pone.0191452.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0191452.e003" xlink:type="simple"/>
<mml:math display="block" id="M3">
<mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mi>K</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>n</mml:mi><mml:mo>−</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac>
</mml:math>
</alternatives>
</disp-formula>
where <italic>p</italic> is the probability that a gene would be targeted at least <italic>k</italic> times from a finite population under sampling without replacement if each gene had an equal probability of being targeted, <italic>N</italic> is the total number of miRNA-gene objects for all miRNA tested in the differential expression experiment, <italic>K</italic> is the number of times a given gene is represented in <italic>N</italic>, <italic>n</italic> is the number of miRNA-genes with parent miRNA that are considered differentially expressed (<italic>p</italic> &lt; 0.05), and <italic>k</italic> is the number of miRNA-gene objects for a given gene represented by differentially expressed miRNA. This analysis was repeated for each miRNA differential expression dataset. The data were filtered for FDR corrected <italic>p</italic>-value &lt; 0.10.</p>
<p>Ensemble Gene Ontology (GO) annotations were obtained using the R Bioconductor (version 3.5) BiomaRt package [<xref ref-type="bibr" rid="pone.0191452.ref027">27</xref>]. The complete list of over-connected genes was filtered to include only GO terms containing “transcription factor” in their annotation. To visualize these results, over-connected gene network graphics were created for several differential expression datasets using the R igraph package (version 1.0.1) [<xref ref-type="bibr" rid="pone.0191452.ref028">28</xref>]. Significantly enriched miRNA-gene objects are represented with miRNA and genes as nodes. Node size reflects the number of connections made to each gene. Network graphics were created for all tissue comparisons with few enough over-connected transcription factors for the network plot to remain sparse enough to be useful.</p>
</sec>
<sec id="sec008">
<title>Gene set enrichment analysis</title>
<p>The R Bioconductor mdgsa package (version 1.8.0) was used for pathway analysis of miRNA differential expression [<xref ref-type="bibr" rid="pone.0191452.ref029">29</xref>]. R (version 3.3.3 (Another Canoe), released on 03/06/2017) was additionally used for all subsequent statistical and computational analyses. The same TargetScan databases used for pathway analysis were used to predict miRNA-gene associations. Pathway-gene associations were taken from the Consensus Pathway Database (ConsensusPathDB, release 31), which combines 32 publically available interaction resources to provide information on protein interaction, signaling reactions, metabolic reactions, gene regulation, genetic interaction, drug-target interaction, and biochemical pathways [<xref ref-type="bibr" rid="pone.0191452.ref030">30</xref>]. See further details in <xref ref-type="supplementary-material" rid="pone.0191452.s015">S1 File</xref>.</p>
<p>Integrated gene set analysis was performed following the method of Garcia-Garcia et al. [<xref ref-type="bibr" rid="pone.0191452.ref031">31</xref>], incorporating the paradigm shift proposed by Godard and Eyall to prevent the influence of knowledge bias [<xref ref-type="bibr" rid="pone.0191452.ref032">32</xref>]. See details in <xref ref-type="supplementary-material" rid="pone.0191452.s015">S1 File</xref>. Following this approach, the pathway database (containing entries linking pathways to genes) was converted to an annotation database containing pathways linked to the miRNA targeting their genes using TargetScan predictions. Gene set analysis was then performed using mdgsa package, which fits a logistic regression model relating the probability of a gene belonging to the gene set with the value of the <italic>r</italic> statistic. The package outputs a log odds ratio for each interrogated gene set, along with raw and false discovery adjusted <italic>p</italic>-values [<xref ref-type="bibr" rid="pone.0191452.ref024">24</xref>]. A positive log odds ratio indicates more targeting of a pathway by miRNA in case 1 compared to case 2 for each case 1 vs. case 2 comparison.</p>
<p>Alternatively, we identified significantly altered pathways using another type of gene set enrichment analysis. This analysis was conducted on the transformed gene expression from the miRNA analysis, which generated <italic>r</italic> statistics for each gene using the Garcia-Garcia method [<xref ref-type="bibr" rid="pone.0191452.ref031">31</xref>]. The subsequent enrichment score is generated using R the Gene Set Variation Analysis (GSVA) package (version 1.24.1) on each gene set using ranking statistics similar to the Kolmogorov-Smirnov test described in Hanzelmann et al [<xref ref-type="bibr" rid="pone.0191452.ref033">33</xref>]. Gene Ontology Pathway Database (Broad Institute, downloaded on 08/16/2017) was the gene set database, assayed in each sample for which it included a total of 5917 gene sets that are known to be involved in biological processes, cellular components and molecular functions [<xref ref-type="bibr" rid="pone.0191452.ref034">34</xref>,<xref ref-type="bibr" rid="pone.0191452.ref035">35</xref>]. The package outputs an GSVA enrichment score for each interrogated gene set. The statistical significance is determined by <italic>p</italic>-values that are calculated using Baysian goodness of fit model using the R limma package (version 3.32.5).</p>
<p>To reduce functional redundancy within the Gene Ontology terms identified with gene set enrichment analysis with GSVA enrichment score, we next used REVIGO (<ext-link ext-link-type="uri" xlink:href="http://revigo.irb.hr/" xlink:type="simple">http://revigo.irb.hr/</ext-link>), a web based program where <italic>sim</italic><sub><italic>Lin</italic></sub> is Lin’s sematic similarity measure [<xref ref-type="bibr" rid="pone.0191452.ref036">36</xref>], <italic>S (c</italic><sub><italic>1</italic></sub>, <italic>c</italic><sub><italic>2</italic></sub><italic>)</italic> is the set of common ancestors of terms <italic>c</italic><sub><italic>1</italic></sub>, <italic>c</italic><sub><italic>2</italic>,</sub> and <italic>p(c)</italic> is the probability of a term [<xref ref-type="bibr" rid="pone.0191452.ref037">37</xref>,<xref ref-type="bibr" rid="pone.0191452.ref038">38</xref>]. The score is termed uniqueness in REVIGO. The previously calculated enrichment <italic>p</italic>-value for each term was not factored into the query since the aim was to reduce functionally overlapping or semantically redundant pathways; however, only significantly enriched terms were included in the query. Given that only one percent of randomly paired terms will be allowed at a uniqueness score of <italic>C</italic> = 0.53, a less stringent <italic>C</italic> = 0.7 was used to allow for a slightly semantically diverse list without significantly compromising the goal of reducing redundancy.</p>
</sec>
<sec id="sec009">
<title>Computational prediction of the miR-183 family targeted genes</title>
<p>To investigate how the miR-183 family targets gene expression in human inner ear development, we performed computational target prediction for the miR-183 family (miRNA-96-5p, miR-182-5p, and miR-183-5p). As miRNA can have numerous targets, we first computationally predict the targets by using a miRNA prediction algorithm, TargetScanHuman (release 7.1: June 2016). TargetScan predicts biological targets of miRNAs by searching for the presence of conserved 8mer, 7mer, and 6mer sites that match the seed region of each miRNA [<xref ref-type="bibr" rid="pone.0191452.ref039">39</xref>,<xref ref-type="bibr" rid="pone.0191452.ref040">40</xref>]. We then compared these results to the Deafness Variation Database (version 8.0), as this database provides a most comprehensive list of genetic variation in genes known to be associated with human deafness (<ext-link ext-link-type="uri" xlink:href="http://deafnessvariationdatabase.org/download" xlink:type="simple">http://deafnessvariationdatabase.org/download</ext-link>) [<xref ref-type="bibr" rid="pone.0191452.ref041">41</xref>,<xref ref-type="bibr" rid="pone.0191452.ref042">42</xref>]. Relevant targets were thereby identified as the intersection of TargetScan predictions and genes associated with deafness as listed in Deafness Variation Database.</p>
</sec>
</sec>
<sec id="sec010" sec-type="results">
<title>Results</title>
<sec id="sec011">
<title>Differential miRNA expression among tissues for three developmental stages</title>
<p>Boxplots are shown in <xref ref-type="fig" rid="pone.0191452.g002">Fig 2</xref> for expression of differentially expressed miRNA where CVG has the highest expression level at three different time points across the three tissue types, CVG, NC, and OV. These results show differentially expressed miRNA with <italic>p</italic> &lt; 0.05 and false discovery rate (FDR) adjusted <italic>p</italic> &lt; 0.25, 0.50, or 0.10 for tissue from Carnegie stages 13, 14, and 15, respectively. The smallest <italic>p</italic>-value out of the three possible tissue comparisons for each miRNA was considered. FDRs were controlled separately for each time point to minimize type II error while still maintaining a reasonable number of results, keeping in mind that a FDR controlled at 0.50 implies that 50% of differential expression results are expected to be false positives. Triplicate measurements were taken by collecting tissue from three different sections of one biological specimen. All three tissue samples within a time point are similarly from a single biological specimen.</p>
<fig id="pone.0191452.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Differential expression of miRNA across tissues.</title>
<p>Differentially expressed miRNA between three tissue types (CVG, NC, and OV) with <italic>p</italic> &lt; 0.05 and false discovery adjusted <italic>p</italic> &lt; 0.25, 0.50, or 0.10 (based on the smallest <italic>p-</italic>value out of the three possible tissue comparisons) are plotted for tissue from Carnegie stages 13, 14, and 15, respectively. MicroRNA from the miR-183 family is circled in red (stage 13) or green (stage 14).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g002" xlink:type="simple"/>
</fig>
<p>Note that at the Carnegie developmental stage 13, members of the miR-183 family (miR-96, miR-182, and miR-183) were highly expressed in CVG and OV as compared with NC (for CVG vs NC comparison, <italic>p</italic> = 0.0009, 0.003, and 0.0045; with FDR correction, <italic>p</italic> = 0.27, 0.40, and 0.41, respectively). Also, note that expression of the entire miR-183 family was the highest in CVG tissue at stage 13 (see red circles on <xref ref-type="fig" rid="pone.0191452.g002">Fig 2</xref>). The trend was not seen at Stage 14, where the only member of the miR-183 family that was upregulated was miR-182 (<italic>p</italic> = 0.004; with FDR correction <italic>p</italic> = 0.27) (indicated with a green circle in <xref ref-type="fig" rid="pone.0191452.g002">Fig 2</xref>). At stage 15, no members of the miR-183 family were observed. Boxplots for expression of the top-20 differentially expressed over the three time points for CVG, NC, and OV are shown in <xref ref-type="supplementary-material" rid="pone.0191452.s003">S2 Fig</xref>.</p>
<p>The top-100 differentially expressed miRNAs in CVG, OV, and NC, and the overlap across tissues, are summarized in <xref ref-type="fig" rid="pone.0191452.g003">Fig 3A</xref> as a Venn diagram. A total of twelve miRNAs were found to be commonly regulated over time in these three tissues; let-7d, let-7e, miR-1249, miR-1254, miR-1255, miR-1273, miR-1285, miR-1301, miR-1306, miR-548, and miR-8078. Differential expression analyses at three developmental time points on these twelves miRNAs are shown in <xref ref-type="fig" rid="pone.0191452.g003">Fig 3B</xref>. The complete set of raw data obtained from HTG Edgeseq miRNA WTA, Quality control files, Brain RNA correction, and normalized data are shown in the <xref ref-type="supplementary-material" rid="pone.0191452.s008">S1 Dataset</xref>. Complete spreadsheets of differential miRNA expression for each tissue comparison and time point are available in the <xref ref-type="supplementary-material" rid="pone.0191452.s009">S2</xref> and <xref ref-type="supplementary-material" rid="pone.0191452.s010">S3</xref> Datasets, respectively.</p>
<fig id="pone.0191452.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Differentially expressed miRNA across time points.</title>
<p>(A) A Venn diagram is presented showing the top 100 miRNAs differentially expressed among the three time points (stages 13, 14, and 15) for each tissue type (CVG, NC, and OV). (B) Normalized counts are plotted for 12 commonly expressed miRNAs that are differentially expressed across time for all three tissues.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g003" xlink:type="simple"/>
</fig>
<p>Principal component analysis (PCA) was performed to visualize potential clustering among samples by either tissue or time point. Principal components 1 and 2 are plotted against one another in <xref ref-type="fig" rid="pone.0191452.g004">Fig 4</xref>. Although there was no tight clustering among samples by tissue or time point, PC2 is moderately associated with tissue type (<xref ref-type="fig" rid="pone.0191452.g004">Fig 4A</xref>, dashed circles). Components are alternatively visualized as the means among technical replicates for a given tissue type and time point with x and y standard error bars (<xref ref-type="fig" rid="pone.0191452.g004">Fig 4B</xref>).</p>
<fig id="pone.0191452.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Principal component analysis.</title>
<p>(A) Principle components 1 and 2 are plotted for the 27 collected datasets. Loose clustering by tissue type is indicated with dashed colored circles. (B) As an alternative visualization, triplicate measures for each individual tissue/time point set are averaged and plotted with x- and y-standard error bars.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>Identification of over-connected transcription factors</title>
<p>To identify differential targeting of transcription factors, genes over-connected to miRNA differential expression datasets were identified by hypergeometric enrichment. The top 10 more-targeted and top 10 less-targeted transcription factors, ranked by significance and filtered for FDR adjusted at <italic>p</italic> &lt; 0.10, are given for CVG vs. NC and CVG vs. OV comparisons for each time point in Tables <xref ref-type="table" rid="pone.0191452.t001">1</xref> and <xref ref-type="table" rid="pone.0191452.t002">2</xref>, respectively. To visualize miRNA targeting of differentially targeted transcription factors, network plots were formed showing transcription factors differentially targeted between CVG and NC tissues (<xref ref-type="fig" rid="pone.0191452.g005">Fig 5</xref>) and between CVG and OV tissues (<xref ref-type="fig" rid="pone.0191452.g006">Fig 6</xref>), as determined by hypergeometric enrichment. Complete data sets on over-connected transcription factors are included in the <xref ref-type="supplementary-material" rid="pone.0191452.s011">S4 Dataset</xref>. Note that, in the group column of the Tables <xref ref-type="table" rid="pone.0191452.t001">1</xref>and <xref ref-type="table" rid="pone.0191452.t002">2</xref>, “up” indicates more targeting of a gene by miRNA in the case (CVG) vs the comparison tissue (NC or OV), and presumably downregulation of the gene itself. In the CVG vs. NC comparison, zinc finger transcription factors (ZNF213, ZNF117, and 138) at stage 13; PELP1 (EGF), PIK3R1 (FGF), SCRT1 (Zinc finger transcription factor), and SKI (TGF-β signaling) at stage 14; and SKOR1 (SMAD binding (inhibiting BMP signaling)) at stage 15 are likely to relevant for CVG development based on prior literature [<xref ref-type="bibr" rid="pone.0191452.ref043">43</xref>,<xref ref-type="bibr" rid="pone.0191452.ref044">44</xref>]. In the CVG vs. OV comparison, CARF (BDNF transcription), EPHA5 (axonal genesis and synapse guidance), LRP6 (Wnt/beta-catenin signaling) at stage 13; and BBS7 (Sonic hedgehog (SHH) signaling) at stage 14 are similarly relevant for CVG development.</p>
<fig id="pone.0191452.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Transcription factor targeting network plots, CVG vs NC comparison.</title>
<p>Network plots showing differentially targeted transcription factors between CVG and NC tissues. Green nodes represent differentially expressed miRNAs, while orange and purple nodes represent significantly (false discovery adjusted <italic>p</italic> &lt; 0.10) targeted transcription factors more targeted in either CVG (purple) or NC (orange) tissue. Transcription factor node size is proportional to the number of differentially expressed miRNAs targeting the gene.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g005" xlink:type="simple"/>
</fig>
<fig id="pone.0191452.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Transcription factor targeting network plots, CVG vs OV comparison.</title>
<p>Network plots showing differentially targeted transcription factors between CVG and OV tissues. Green nodes represent differentially expressed miRNAs, while orange and purple nodes represent significantly (false discovery adjusted <italic>p</italic> &lt; 0.10) targeted transcription factors more targeted in either CVG (purple) or OV (orange) tissue. Transcription factor node size is proportional to the number of differentially expressed miRNAs targeting the gene. Only results for stages 13 and 15 are shown, as there are too many significant factors to effectively visualize at stage 14.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g006" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0191452.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.t001</object-id>
<label>Table 1</label> <caption><title>Differentially targeted transcription factors, CVG vs NC comparison.</title></caption>
<alternatives>
<graphic id="pone.0191452.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene Symbol</th>
<th align="left">Group</th>
<th align="left"><italic>p</italic> value</th>
<th align="left">Adjusted <italic>p</italic> value</th>
<th align="left">Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">ZNF213</td>
<td align="left">Down, Stage 13</td>
<td align="left">1.70E-06</td>
<td align="left">1.64E-02</td>
<td align="left">Zinc finger transcription factor; controls neurogenesis</td>
</tr>
<tr>
<td align="left">ZNF117</td>
<td align="left">Up, Stage 13</td>
<td align="left">9.29E-06</td>
<td align="left">2.99E-02</td>
<td align="left">Zinc finger transcription factor; controls neurogenesis</td>
</tr>
<tr>
<td align="left">ZNF138</td>
<td align="left">Up, Stage 13</td>
<td align="left">1.10E-07</td>
<td align="left">2.13E-03</td>
<td align="left">Zinc finger transcription factor; controls neurogenesis</td>
</tr>
<tr>
<td align="left">BCL6</td>
<td align="left">Down, Stage 14</td>
<td align="left">8.53E-05</td>
<td align="left">3.66E-02</td>
<td align="left">Zinc finger transcription factor; controls neurogenesis through NOTCH-dependent transcriptional complexes at targets</td>
</tr>
<tr>
<td align="left">E2F7</td>
<td align="left">Down, Stage 14</td>
<td align="left">3.20E-04</td>
<td align="left">8.58E-02</td>
<td align="left">Directly repressed classical E2F transcription factors such as E2F1</td>
</tr>
<tr>
<td align="left">IL1RAP</td>
<td align="left">Down, Stage 14</td>
<td align="left">5.62E-05</td>
<td align="left">2.78E-02</td>
<td align="left">May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons</td>
</tr>
<tr>
<td align="left">NFE2L3</td>
<td align="left">Down, Stage 14</td>
<td align="left">9.33E-05</td>
<td align="left">3.83E-02</td>
<td align="left">Leucine zipper transcription factor</td>
</tr>
<tr>
<td align="left">PELP1</td>
<td align="left">Down, Stage 14</td>
<td align="left">1.83E-04</td>
<td align="left">6.19E-02</td>
<td align="left">Interacts with growth factor signaling components EGFR</td>
</tr>
<tr>
<td align="left">PIK3R1</td>
<td align="left">Down, Stage 14</td>
<td align="left">1.06E-07</td>
<td align="left">2.92E-04</td>
<td align="left">Role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4</td>
</tr>
<tr>
<td align="left">PITX1</td>
<td align="left">Up, Stage 14</td>
<td align="left">1.19E-04</td>
<td align="left">8.49E-02</td>
<td align="left">Identity/structure of hindlimb; DAG and IP3 signaling</td>
</tr>
<tr>
<td align="left">SCRT1</td>
<td align="left">Up, Stage 14</td>
<td align="left">1.09E-05</td>
<td align="left">1.97E-02</td>
<td align="left">Zinc finger transcription factor; promotes neural differentiation</td>
</tr>
<tr>
<td align="left">SKI</td>
<td align="left">Up, Stage 14</td>
<td align="left">3.35E-05</td>
<td align="left">3.57E-02</td>
<td align="left">Receptor of TGF-β signaling; neural tube development</td>
</tr>
<tr>
<td align="left">SKOR1</td>
<td align="left">Down, Stage 15</td>
<td align="left">1.11E-05</td>
<td align="left">3.05E-02</td>
<td align="left">SMAD binding (inhibiting BMP signaling)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>down: transcription factors less targeted by miRNA; up: transcription factors more targeted by miRNA; stage: the Carnegie embryonic stage. GeneCards® (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org" xlink:type="simple">www.genecards.org</ext-link>) was used for Notes [<xref ref-type="bibr" rid="pone.0191452.ref045">45</xref>].</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0191452.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.t002</object-id>
<label>Table 2</label> <caption><title>Differentially targeted transcription factors, CVG vs OV comparison.</title></caption>
<alternatives>
<graphic id="pone.0191452.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene<break/>Symbol</th>
<th align="left">Group</th>
<th align="left"><italic>p value</italic></th>
<th align="left">Adjusted<break/><italic>p</italic> value</th>
<th align="left">Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">ZNF121</td>
<td align="left">Down, Stage 13</td>
<td align="left">1.63E-07</td>
<td align="left">2.43E-04</td>
<td align="left">Transcription regulation</td>
</tr>
<tr>
<td align="left">TRIM13</td>
<td align="left">Down, Stage 13</td>
<td align="left">2.12E-06</td>
<td align="left">1.41E-03</td>
<td align="left">Involved in turnover of membrane and secretory proteins from the endoplasmic reticulum; signal transducer activity</td>
</tr>
<tr>
<td align="left">MED6</td>
<td align="left">Down, Stage 13</td>
<td align="left">7.83E-06</td>
<td align="left">3.63E-03</td>
<td align="left">Transcription cofactor</td>
</tr>
<tr>
<td align="left">NR1D2</td>
<td align="left">Down, Stage 13</td>
<td align="left">2.55E-05</td>
<td align="left">8.95E-03</td>
<td align="left">Transcriptional repressor regulating genes involved in circadian rhythm, metabolic function, and inflammatory response</td>
</tr>
<tr>
<td align="left">PELP1</td>
<td align="left">Down, Stage 13</td>
<td align="left">5.66E-05</td>
<td align="left">1.40E-02</td>
<td align="left">Interacts with growth factor signaling components EGFR</td>
</tr>
<tr>
<td align="left">HOXC4</td>
<td align="left">Down, Stage 13</td>
<td align="left">6.78E-05</td>
<td align="left">1.56E-02</td>
<td align="left">Developmental gene related to anterior-posterior positioning</td>
</tr>
<tr>
<td align="left">ZXDA</td>
<td align="left">Down, Stage 13</td>
<td align="left">7.08E-05</td>
<td align="left">1.59E-02</td>
<td align="left">Promotes transcription of MHC class I and II genes</td>
</tr>
<tr>
<td align="left">ZNF140</td>
<td align="left">Down, Stage 13</td>
<td align="left">1.00E-04</td>
<td align="left">2.05E-02</td>
<td align="left">Transcriptional repressor</td>
</tr>
<tr>
<td align="left">CREBRF</td>
<td align="left">Down, Stage 13</td>
<td align="left">1.20E-04</td>
<td align="left">2.39E-02</td>
<td align="left">Negative regulator of endoplasmic reticulum stress response by CREB3 regulation</td>
</tr>
<tr>
<td align="left">ZNF675</td>
<td align="left">Down, Stage 13</td>
<td align="left">1.41E-04</td>
<td align="left">2.67E-02</td>
<td align="left">Transcriptional regulation; involved in osteoclast differentiation by modulating TRAF6 signaling</td>
</tr>
<tr>
<td align="left">SHOX</td>
<td align="left">Up, Stage 13</td>
<td align="left">4.89E-05</td>
<td align="left">7.87E-02</td>
<td align="left">Controls growth and development</td>
</tr>
<tr>
<td align="left">CREBRF</td>
<td align="left">Up, Stage 15</td>
<td align="left">3.49E-09</td>
<td align="left">8.42E-06</td>
<td align="left">Negative regulator of endoplasmic reticulum stress response by CREB3 regulation</td>
</tr>
<tr>
<td align="left">RORA</td>
<td align="left">Up, Stage 15</td>
<td align="left">1.63E-07</td>
<td align="left">1.43E-04</td>
<td align="left">Key regulator of differentiation, development, immunity, circadian rhythm; regulates SHH expression and calcium-mediated signal transduction</td>
</tr>
<tr>
<td align="left">PURA</td>
<td align="left">Up, Stage 15</td>
<td align="left">2.91E-07</td>
<td align="left">2.01E-04</td>
<td align="left">Transcription activator</td>
</tr>
<tr>
<td align="left">ZNF148</td>
<td align="left">Up, Stage 15</td>
<td align="left">5.50E-07</td>
<td align="left">3.43E-04</td>
<td align="left">Transcriptional regulator; mutations associated with global developmental delay</td>
</tr>
<tr>
<td align="left">NFAT5</td>
<td align="left">Up, Stage 15</td>
<td align="left">7.85E-07</td>
<td align="left">4.74E-04</td>
<td align="left">T-cell related transcription factor, immune response</td>
</tr>
<tr>
<td align="left">CREBZF</td>
<td align="left">Up, Stage 15</td>
<td align="left">1.14E-06</td>
<td align="left">5.32E-04</td>
<td align="left">Suppresses transcriptional activation by CREB3</td>
</tr>
<tr>
<td align="left">EPM2AIP1</td>
<td align="left">Up, Stage 15</td>
<td align="left">2.37E-06</td>
<td align="left">7.84E-04</td>
<td align="left">Binds laforin, function unknown; mutations associated with epilepsy</td>
</tr>
<tr>
<td align="left">EPHA5</td>
<td align="left">Up, Stage 15</td>
<td align="left">2.86E-06</td>
<td align="left">8.37E-04</td>
<td align="left">Mediates nervous system development, role in axon guidance and synaptogenesis</td>
</tr>
<tr>
<td align="left">POU3F4</td>
<td align="left">Up, Stage 15</td>
<td align="left">2.82E-06</td>
<td align="left">8.37E-04</td>
<td align="left">Neural transcription factor, plays a role in inner ear development</td>
</tr>
<tr>
<td align="left">RFX3</td>
<td align="left">Up, Stage 15</td>
<td align="left">3.40E-06</td>
<td align="left">9.66E-04</td>
<td align="left">Transcriptional activator, involved in differentiation during embryogenesis</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>down: transcription factors less targeted by miRNA; up: transcription factors more targeted by miRNA; stage: the Carnegie embryonic stage. GeneCards® (<ext-link ext-link-type="uri" xlink:href="http://www.genecard.org" xlink:type="simple">www.genecard.org</ext-link>) was used for Notes [<xref ref-type="bibr" rid="pone.0191452.ref045">45</xref>].</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Gene set enrichment analysis</title>
<p>To understand tissue specific gene expression profiles that are important to human inner ear development, differentially expressed pathways were determined for each tissue comparison and time point based on miRNA differential expression datasets. The top 16 up- and down-regulated pathways, ranked by significance, are included in <xref ref-type="table" rid="pone.0191452.t003">Table 3</xref> (CVG vs. NC) and 4 (CVG vs. OV), respectively. Note that a positive log odds ratio implies more miRNA targeting of a pathway, and therefore presumably inhibition of the pathway itself. In the CVG vs. NC comparison, the Dicer pathway, Insulin growth factor-1 (IGF-1) pathway, activated point mutants of FGFR2, and regulation of commissural axon pathfinding by SLIT and ROBO are likely relevant for CVG development (<xref ref-type="table" rid="pone.0191452.t003">Table 3</xref>), because they have negative log odds ratios, and are thus less likely to be inhibited by miRNAs and more likely to be enriched in the ganglion as compared to the NC. In the CVG vs. OV comparison, regulation of commissural axon pathfinding by SLIT and ROBO is once again likely relevant for CVG development (<xref ref-type="table" rid="pone.0191452.t004">Table 4</xref>). Complete differential pathway analyses data are included in the <xref ref-type="supplementary-material" rid="pone.0191452.s012">S5 Dataset</xref>.</p>
<table-wrap id="pone.0191452.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.t003</object-id>
<label>Table 3</label> <caption><title>Enriched gene sets, CVG vs NC comparison.</title></caption>
<alternatives>
<graphic id="pone.0191452.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Pathway</th>
<th align="left">LOR</th>
<th align="left"><italic>p</italic> value</th>
<th align="left">Adjusted <italic>p</italic> value</th>
<th align="left">Time point</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Dicer pathway</td>
<td align="left">-0.32</td>
<td align="left">4.06E-09</td>
<td align="left">1.35E-04</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Mitotic anaphase</td>
<td align="left">-0.31</td>
<td align="left">2.56E-06</td>
<td align="left">3.43E-02</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Trafficking of myristoylated proteins to the cilium</td>
<td align="left">-0.26</td>
<td align="left">3.09E-06</td>
<td align="left">3.43E-02</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Inhibition of cellular proliferation by GLEEVEC</td>
<td align="left">-0.26</td>
<td align="left">7.61E-06</td>
<td align="left">6.34E-02</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Metastatic brain tumor</td>
<td align="left">-0.43</td>
<td align="left">2.34E-05</td>
<td align="left">1.56E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Zinc efflux and compartmentalization by the SLC30 family</td>
<td align="left">-0.21</td>
<td align="left">8.61E-05</td>
<td align="left">4.65E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">A tetrasaccharide linker sequence is required for GAG synthesis</td>
<td align="left">-0.22</td>
<td align="left">9.81E-05</td>
<td align="left">4.65E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Teniposide Action Pathway</td>
<td align="left">-0.26</td>
<td align="left">1.32E-04</td>
<td align="left">4.65E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Teniposide Metabolism Pathway</td>
<td align="left">-0.26</td>
<td align="left">1.32E-04</td>
<td align="left">4.65E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Butanoate metabolism</td>
<td align="left">-0.26</td>
<td align="left">1.40E-04</td>
<td align="left">4.65E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">IGF-1 signaling pathway</td>
<td align="left">-0.20</td>
<td align="left">1.76E-04</td>
<td align="left">5.11E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Prostaglandin formation from arachidonate</td>
<td align="left">-0.26</td>
<td align="left">1.97E-04</td>
<td align="left">5.11E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">RIG-I-like receptor signaling pathway</td>
<td align="left">-0.24</td>
<td align="left">2.07E-04</td>
<td align="left">5.11E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Constitutive signaling by AKT1 E17K in cancer</td>
<td align="left">-0.21</td>
<td align="left">2.15E-04</td>
<td align="left">5.11E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Hyaluronan biosynthesis and export</td>
<td align="left">-0.27</td>
<td align="left">2.61E-04</td>
<td align="left">5.81E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left"><italic>S</italic>-methyl-5-thio-&amp;alpha;-D-ribose 1-phosphate degradation</td>
<td align="left">-0.25</td>
<td align="left">3.53E-04</td>
<td align="left">6.86E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Plasmalogen biosynthesis</td>
<td align="left">-0.27</td>
<td align="left">1.25E-06</td>
<td align="left">4.17E-02</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Activated point mutants of FGFR2</td>
<td align="left">-0.29</td>
<td align="left">3.90E-06</td>
<td align="left">6.49E-02</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Spermine biosynthesis</td>
<td align="left">-0.21</td>
<td align="left">6.94E-05</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Formaldehyde oxidation</td>
<td align="left">-0.21</td>
<td align="left">7.82E-05</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Heart development</td>
<td align="left">-0.21</td>
<td align="left">1.76E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Synthesis of CL</td>
<td align="left">-0.21</td>
<td align="left">1.96E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Copper homeostasis</td>
<td align="left">-0.22</td>
<td align="left">1.98E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">NR1D1 (REV-ERBA) represses gene expression</td>
<td align="left">-0.21</td>
<td align="left">2.02E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Pyrimidine deoxyribonucleotides <italic>de novo</italic> biosynthesis</td>
<td align="left">-0.25</td>
<td align="left">2.03E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Ion transport by P-type ATPases</td>
<td align="left">-0.23</td>
<td align="left">2.16E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Adenine and adenosine salvage II</td>
<td align="left">-0.24</td>
<td align="left">2.24E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Interleukin-6 signaling</td>
<td align="left">-0.20</td>
<td align="left">2.30E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Synthesis of UDP-N-acetyl-glucosamine</td>
<td align="left">-0.20</td>
<td align="left">2.34E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">UDP-<italic>N</italic>-acetyl-D-glucosamine biosynthesis II</td>
<td align="left">-0.20</td>
<td align="left">2.34E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Regulatory RNA pathways</td>
<td align="left">-0.25</td>
<td align="left">2.38E-04</td>
<td align="left">5.27E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Regulation of commissural axon pathfinding by SLIT and ROBO</td>
<td align="left">-0.21</td>
<td align="left">2.55E-04</td>
<td align="left">5.30E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Fatty acid elongation—saturated</td>
<td align="left">-0.26</td>
<td align="left">1.28E-05</td>
<td align="left">4.26E-01</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Hypusine biosynthesis</td>
<td align="left">-0.44</td>
<td align="left">6.54E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Doxorubicin pathway (cancer cell), pharmacodynamics</td>
<td align="left">0.23</td>
<td align="left">7.66E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 15</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>LOR: Logarithm Odds Ratio.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0191452.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.t004</object-id>
<label>Table 4</label> <caption><title>Enriched gene sets, CVG vs OV comparison.</title></caption>
<alternatives>
<graphic id="pone.0191452.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Pathway</th>
<th align="left">LOR</th>
<th align="left"><italic>p</italic> value</th>
<th align="left">Adjusted <italic>p</italic> value</th>
<th align="left">Time point</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Fatty acid elongation—saturated</td>
<td align="left">0.25</td>
<td align="left">2.44E-05</td>
<td align="left">5.92E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Synthesis and processing of ENV and VPU</td>
<td align="left">0.29</td>
<td align="left">3.55E-05</td>
<td align="left">5.92E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Synthesis of UDP-<italic>N</italic>-acetyl-glucosamine</td>
<td align="left">-0.20</td>
<td align="left">1.33E-04</td>
<td align="left">9.94E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">UDP-<italic>N</italic>-acetyl-D-glucosamine biosynthesis II</td>
<td align="left">-0.20</td>
<td align="left">1.33E-04</td>
<td align="left">9.94E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Acyl chain remodeling of DAG and TAG</td>
<td align="left">0.21</td>
<td align="left">1.49E-04</td>
<td align="left">9.94E-01</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">ERK1/ERK2 MAPK signaling pathway</td>
<td align="left">0.22</td>
<td align="left">1.86E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">GDP-mannose biosynthesis</td>
<td align="left">0.22</td>
<td align="left">3.99E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">FGFR4 mutant receptor activation</td>
<td align="left">0.35</td>
<td align="left">4.28E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Degradation of the RAR and RXR by the proteasome</td>
<td align="left">0.20</td>
<td align="left">4.35E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Propionyl-CoA catabolism</td>
<td align="left">-0.23</td>
<td align="left">6.89E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane</td>
<td align="left">-0.23</td>
<td align="left">9.93E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 13</td>
</tr>
<tr>
<td align="left">Fatty acid elongation—saturated</td>
<td align="left">0.26</td>
<td align="left">8.88E-06</td>
<td align="left">1.48E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Reactions specific to the hybrid N-glycan synthesis pathway</td>
<td align="left">0.24</td>
<td align="left">1.38E-05</td>
<td align="left">1.54E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Acyl chain remodeling of DAG and TAG</td>
<td align="left">0.22</td>
<td align="left">5.59E-05</td>
<td align="left">4.65E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Saturated fatty acids beta-oxidation</td>
<td align="left">0.31</td>
<td align="left">7.24E-05</td>
<td align="left">4.83E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Synthesis and processing of ENV and VPU</td>
<td align="left">0.27</td>
<td align="left">8.97E-05</td>
<td align="left">4.98E-01</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Vitamins B6 activation to pyridoxal phosphate</td>
<td align="left">0.19</td>
<td align="left">2.67E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">ChREBP activates metabolic gene expression</td>
<td align="left">0.23</td>
<td align="left">4.16E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Synthesis of GDP-mannose</td>
<td align="left">0.21</td>
<td align="left">5.88E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Degradation of the RAR and RXR by the proteasome</td>
<td align="left">0.19</td>
<td align="left">7.54E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Arachidonate production from DAG</td>
<td align="left">0.19</td>
<td align="left">9.31E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Activation of CSK by camp-dependent protein kinase inhibits signaling through the T-cell receptor</td>
<td align="left">0.21</td>
<td align="left">9.70E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left"><italic>S</italic>-adenosyl-<italic>L</italic>-methionine biosynthesis</td>
<td align="left">0.18</td>
<td align="left">9.72E-04</td>
<td align="left">1.00E+00</td>
<td align="left">Stage 14</td>
</tr>
<tr>
<td align="left">Macroautophagy</td>
<td align="left">0.33</td>
<td align="left">1.37E-07</td>
<td align="left">4.56E-03</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Plasmalogen synthesis</td>
<td align="left">0.32</td>
<td align="left">1.33E-06</td>
<td align="left">1.57E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">BMI1</td>
<td align="left">0.36</td>
<td align="left">2.40E-06</td>
<td align="left">1.57E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Excitatory neural signaling through 5-HTR 7 and serotonin</td>
<td align="left">0.26</td>
<td align="left">2.74E-06</td>
<td align="left">1.57E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">The 41bb-dependent immune response</td>
<td align="left">0.25</td>
<td align="left">3.02E-06</td>
<td align="left">1.57E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Mitochondrial transcription initiation</td>
<td align="left">0.27</td>
<td align="left">3.29E-06</td>
<td align="left">1.57E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Regulation of commissural axon pathfinding by SLIT and ROBO</td>
<td align="left">0.27</td>
<td align="left">3.29E-06</td>
<td align="left">1.57E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Phosphorylation of proteins involved in the G2/M transition by Cyclin A: CDC2 complexes</td>
<td align="left">0.37</td>
<td align="left">4.05E-06</td>
<td align="left">1.69E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">D4GDI signaling pathway</td>
<td align="left">0.32</td>
<td align="left">5.05E-06</td>
<td align="left">1.87E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Herpes simplex infection</td>
<td align="left">0.30</td>
<td align="left">6.33E-06</td>
<td align="left">2.11E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Early phase of HIV life cycle</td>
<td align="left">0.27</td>
<td align="left">9.16E-06</td>
<td align="left">2.77E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Plasmalogen biosynthesis</td>
<td align="left">0.24</td>
<td align="left">1.06E-05</td>
<td align="left">2.88E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">DAP12 interactions</td>
<td align="left">0.25</td>
<td align="left">1.13E-05</td>
<td align="left">2.88E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Hypoxia-mediated EMT and stemness</td>
<td align="left">0.32</td>
<td align="left">1.25E-05</td>
<td align="left">2.95E-02</td>
<td align="left">Stage 15</td>
</tr>
<tr>
<td align="left">Gefitinib Pathway, Pharmacokinetics</td>
<td align="left">0.27</td>
<td align="left">1.33E-05</td>
<td align="left">2.95E-02</td>
<td align="left">Stage 15</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>LOR: Logarithm Odds Ratio.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Since each method for performing pathway analysis can have method dependent bias, we additionally performed a non-parametric analysis using the concept of gene set enrichment analysis [<xref ref-type="bibr" rid="pone.0191452.ref033">33</xref>] on the gene expression profile predicted from the miRNA expression pattern in CVG, OV and NC. From this analysis, we again identified functional gene sets defined in Gene Ontology terms that are positively or negatively enriched in each tissue type at different time points (<xref ref-type="fig" rid="pone.0191452.g007">Fig 7</xref>). <xref ref-type="fig" rid="pone.0191452.g007">Fig 7</xref> shows two signatures of the differentially activated Gene Ontology pathways by GSVA analysis in CVG vs. NC comparison (<xref ref-type="fig" rid="pone.0191452.g007">Fig 7A</xref>) and CVG vs. OV (<xref ref-type="fig" rid="pone.0191452.g007">Fig 7B</xref>) in heatmap format. Using this method, we found that different numbers of pathways were identified as significantly enriched when comparing different tissue types at different stages of development (<xref ref-type="supplementary-material" rid="pone.0191452.s006">S5 Fig</xref>), with stage 15 having highest number of enriched pathways (209 pathways) when comparing CVG to NC or OV. To generate a signature, any pathway that was significantly enriched either positively or negatively at <italic>p</italic>-&lt;0.05 in at least one time point was included in the heatmap. Note that there are many GO term pathways directly relevant to CVG development (<xref ref-type="fig" rid="pone.0191452.g007">Fig 7C and 7D</xref>). These include Wnt activated receptor activity, ganglion development, axon extension, positive regulation of neuron migration, and integrin mediated cell adhesion (higher GSVA score in Stage 15) at different time points (<xref ref-type="fig" rid="pone.0191452.g007">Fig 7D</xref>) while most common category of Gene Ontology terms for all comparisons are pathways involved in general biological processes (shown in blue bars in <xref ref-type="supplementary-material" rid="pone.0191452.s006">S5 Fig</xref>). To better focus on the biological processes that are enriched in different tissue types, we additionally performed the REVIGO analysis described in Supek et al., removing pathways that are functionally redundant after analyzing Gene Ontology classification [<xref ref-type="bibr" rid="pone.0191452.ref046">46</xref>] (<xref ref-type="fig" rid="pone.0191452.g008">Fig 8</xref>). Specific themes and processes were identified comparing Gene Ontology terms identified in CVG when comparing to NC at stage 13 (<xref ref-type="fig" rid="pone.0191452.g008">Fig 8</xref>) and at stage 14 (<xref ref-type="supplementary-material" rid="pone.0191452.s007">S6 Fig</xref>). For example, six overarching biological processes were identified by examining enriched pathways at developmental stage 13 when comparing CVG to NC: regulation of lipoprotein metabolism, oligosaccharide biosynthesis, response to inactivity, hemidesome assembly, sarcoplasmic reticulum calcium ion transport, and replicative senescence. Note that replicative senescence includes pathways that are likely to relevant to CVG development such as auditory cell development and dorsal spinal cord development (red circled in <xref ref-type="fig" rid="pone.0191452.g008">Fig 8</xref>). A complete list of all enriched pathways is available in the <xref ref-type="supplementary-material" rid="pone.0191452.s013">S6 Dataset</xref>.</p>
<fig id="pone.0191452.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Differentially activated gene ontological pathways by GSVA analysis.</title>
<p>Heatmap comparison of CVG with NC (A), and of CVG with OV (B). Each column represents the sample indicated at the top (three time points), each row represents an identified GO Term pathway (see the complete set in the <xref ref-type="supplementary-material" rid="pone.0191452.s013">S6 Dataset</xref>). The expression levels of GSVA scores are depicted according to the color scale (middle right). Red or green indicate expression levels above or below the median, respectively. The magnitude of deviation from the median is represented by color saturation. Heatmaps representing the GSVA score of GO term pathways relevant to CVG development that are significantly modulated in CVG. vs. NC comparison (C) and CVG vs. OV (D).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g007" xlink:type="simple"/>
</fig>
<fig id="pone.0191452.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.g008</object-id>
<label>Fig 8</label>
<caption>
<title>REVIGO treemap of relevance similarity analysis on enriched pathways comparing CVG vs. NC (stage 13).</title>
<p>REVIGO treemap summarizing Gene Ontology biological process categories over-represented in CVG cells compared to NC cells at stage 13. All terms are included with a FDR adjusted <italic>p</italic>-value cutoff at 0.05 from the enrichment analysis. The relevance similarity C-score (uniqueness) cut-off is chosen at 0.7. The size of each rectangle is proportional to the uniqueness for that category. Red circles indicate relevant CVG-development pathways.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.g008" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>Computational prediction of the miR-183 family targeted genes</title>
<p>To further investigate how the miR-183 family targeted genes are expressed in the inner ear (CVG) development in humans, we computationally predicted miR-183 family targeted genes using TargetScanHuman (release 7.1). More than 1,000 genes were identified (complete datasets are included in <xref ref-type="supplementary-material" rid="pone.0191452.s014">S7 Dataset</xref>). The Deafness Variation Database (version 8.0) was then used to identify the targets that are associated with human hereditary hearing loss and deafness. <xref ref-type="table" rid="pone.0191452.t005">Table 5</xref> shows the list of predicted miR-183 family target genes that are relevant to human hereditary hearing loss and deafness.</p>
<table-wrap id="pone.0191452.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191452.t005</object-id>
<label>Table 5</label> <caption><title>Predicted target genes for the MiR-183 family using TagetScanHuman and a Deafness Variation Database (version 8.0).</title></caption>
<alternatives>
<graphic id="pone.0191452.t005g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.t005" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">miRNA</th>
<th align="center">Predicted target genes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">miR-183 family</td>
<td align="left"><italic>MITF</italic>, <italic>TECTB</italic>, <italic>EDNRB</italic>, <italic>CD164</italic>, <italic>OSBPL2</italic>, <italic>MET</italic>, <italic>CLIC5</italic>, <italic>GRHL2</italic>, <italic>COL4A4</italic>, <italic>TBX1</italic>, <italic>RDX</italic>,<break/><italic>S1PR2</italic>, <italic>CCDC50</italic>, <italic>PNPT1</italic>, <italic>PEX6</italic>, <italic>SLC26A4</italic>, <italic>OTOG</italic>, <italic>COL9A1</italic>, <italic>COL4A6</italic>, <italic>PTPRQ</italic></td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
</sec>
<sec id="sec015" sec-type="conclusions">
<title>Discussion/conclusions</title>
<p>Due to inaccessibility of human inner ear tissue, prior miRNA expression studies have been limited to animals, and in particular, mouse models [<xref ref-type="bibr" rid="pone.0191452.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0191452.ref047">47</xref>–<xref ref-type="bibr" rid="pone.0191452.ref050">50</xref>]. Further, the standard use in the United States and elsewhere of suction curettage (51), which generally renders embryonic structures unidentifiable, now makes it difficult even to obtain human tissue for study. However, the development of techniques for analyzing miRNA expression, along with the FFPE specimens provided by the Bruska group, enabled us to perform these novel analyses of human embryonic tissues. Note that due to the small sample size, our results should be cautiously assessed; bearing in mind that differential expression across time points can be confounded by biological noise, while differences among tissues could be specific to the sampled individual.</p>
<p>The differential expression of miR-183 family members (miR-96-5p, miR-182-5p, and miR-183-5p) in human CVG cell types at stage 13 correlates well with prior studies in mice. Weston et al. found that expression of the triad of miR-96, miR182, and miR-183 during development is relatively restricted to mouse inner ear compared to brain, heart, and whole embryo [<xref ref-type="bibr" rid="pone.0191452.ref003">3</xref>]. Sacheli et al. noted the earliest expression of miR-183 and miR-182 in the mouse otic vesicle at embryonic day 9. (E9.5), expression of all three miRNAs in OV, CVG, and neural tube at E11.5, and limited expression was observed at E14.5 [<xref ref-type="bibr" rid="pone.0191452.ref051">51</xref>]. By P0, this triad was strongly expressed in hair cells of the cochlea and vestibular system, as well as in the SGNs. We found that in human CVG, the miRNA-183 family was differentially expressed at stage 13 (E11), but only miR-182-5p was expressed at stage 14 (E11.5), and the miRNA family was not differentially expressed at stage 15 (E12). This may reflect differences between mouse and human development, but the small sample size in this study limits firm conclusions. Regardless, our findings suggest that the miR-183 family is important in human as well as murine inner ear development.</p>
<p>Twelve miRNAs out of the 100 most differentially expressed miRNAs across three time points were commonly expressed in all three tissues as presented in our Venn diagram (<xref ref-type="fig" rid="pone.0191452.g003">Fig 3</xref>). The majority of the common miRNAs (let-7 family, miRNA 548, 1255, 1273, 1285, 1301, and 1306) are involved in developmental timing, cell proliferation, cell-cycle regulation, and apoptosis [<xref ref-type="bibr" rid="pone.0191452.ref052">52</xref>,<xref ref-type="bibr" rid="pone.0191452.ref053">53</xref>]. Also, miR-1254 is known to regulate the epithelial to mesenchymal transition (EMT) [<xref ref-type="bibr" rid="pone.0191452.ref054">54</xref>]. EMT plays an important role in the delamination and escape through into the mesenchyme of both neural crest cells and placodal sensory neurons such as CVG [<xref ref-type="bibr" rid="pone.0191452.ref055">55</xref>]. The commonality of expression of these twelve miRNAs among the CVG, OV, and NC cell types suggests that these miRNAs are involved in both inner ear and neural crest development.</p>
<p>The over-connected transcription factor analysis revealed a number of transcription factors that are known to be involved in CVG development in mice. For example, SKI was found to be upregulated in the CVG. vs. NC comparison, indicating more inhibition of SKI by miRNA in the CVG. SKI family transcription factors have been known to downregulate TGF-β signaling in mice thereby promoting neuronal induction including in the CVG [<xref ref-type="bibr" rid="pone.0191452.ref056">56</xref>]. CARF (BDNF transcription, stage 13), EPHA5 (axonal genesis and synapse guidance, stage 13), LRP6 (Wnt/beta-catenin signaling, stage 13), and BBS7 (Sonic hedgehog (SHH) signaling, stage 14) have been previously shown to be relevant in mouse CVG development [<xref ref-type="bibr" rid="pone.0191452.ref057">57</xref>]. Other transcription factors identified by our analysis could represent important developmental effectors that have not been identified previously; our data thus has the potential to generate a series of follow up experiments to investigate development in the CVG, NC, and OV.</p>
<p>Our initial gene set enrichment analysis revealed that the Dicer, IGF-1, and FGFR2 pathways (stage 13) and regulation of commissural axon pathfinding by SLIT and ROBO (stage 14 and 15) were relevant ontogenetic pathways for CVG development. The Dicer pathway was the most statistically significant ontogenetic pathway at stage 13 in humans. A previous study in the mouse inner ear has shown that progressive reduction of miR-183 expression after <italic>Pax2</italic>-Cre conditional <italic>Dicer</italic> knockout (KO) results in progressive loss of neurosensory gene expression, arrested neurosensory development and loss of CVGs with an associated disruption of morphogenesis [<xref ref-type="bibr" rid="pone.0191452.ref004">4</xref>]. More recently, a <italic>Dicer1</italic> conditional KO line (<italic>Atoh1-cre;Dicer1</italic> <sup><italic>flox/flox</italic></sup> <italic>and Foxg1-cre; Dicer1</italic> <sup><italic>flox/flox</italic></sup>) showed defects in proliferation in the prosensory domain of the cochlea including CVGs [<xref ref-type="bibr" rid="pone.0191452.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0191452.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0191452.ref058">58</xref>]. Our observations coupled with the findings in mice suggest that Dicer pathway interactions with the miR-183 family play an essential role in the regulation of early mice inner ear development. Similarly, previous studies in mouse demonstrated that FGF2 signaling through FGFR2 and endogenous IGF-1 signaling are necessary for development of SGNs [<xref ref-type="bibr" rid="pone.0191452.ref059">59</xref>–<xref ref-type="bibr" rid="pone.0191452.ref061">61</xref>], consistent with our findings in the embryonic human inner ear.</p>
<p>In addition to identifying novel regulatory pathways derived from differential miRNA expression in specific embryonic inner ear tissues, we found that many of the enriched pathways occur at different stages of inner ear development. While comparing CVG to NC and OV, we observed that many more pathways were significantly enriched at stage 15, but that regulatory pathways of inner ear development, neurogenesis or axis patterning seemed to occur earlier at stages 13 and 14. Specifically, pathways involved in auditory receptor cell morphogenesis as well as many cell fate determination and pattering pathways were enriched in CVG at stages 13 and 14. By contrast, many of the pathways enriched in stage 15 are related to biosynthesis, metabolism and proliferation, suggesting that this is likely an embryonic stage allowing for growth after cell fate determination has already occurred.</p>
<p>Identification of miRNA-targeted genes is one of the most significant elements for understanding the function of a miRNA in the human inner ear development [<xref ref-type="bibr" rid="pone.0191452.ref047">47</xref>]. Among our predicted miR-183 family targeted genes that are related to human inner ear (CVG) development (<xref ref-type="table" rid="pone.0191452.t005">Table 5</xref>), it is worthwhile to mention <italic>TBX1</italic> (T-box domain 1), as a previous study has confirmed <italic>tbx-1</italic> as one of target genes for the conserved miR-183 family in a mouse model [<xref ref-type="bibr" rid="pone.0191452.ref062">62</xref>]. <italic>Tbx1</italic> was required for morphogenesis and growth of the murine otocyst [<xref ref-type="bibr" rid="pone.0191452.ref063">63</xref>]. In humans, <italic>TBX1</italic> is a critical gene in DiGeorge syndrome, with patients presenting phenotypes including inner ear abnormalities, sensorineural hearing loss [<xref ref-type="bibr" rid="pone.0191452.ref064">64</xref>–<xref ref-type="bibr" rid="pone.0191452.ref066">66</xref>], and vestibular loss [<xref ref-type="bibr" rid="pone.0191452.ref067">67</xref>,<xref ref-type="bibr" rid="pone.0191452.ref068">68</xref>]. Therefore, we speculate that the transcriptional regulation of <italic>TBX1</italic> in human may be influenced by the miR-183 family, providing a crucial function in developmental signaling pathways in the human inner ear.</p>
<p>It should be noted that this study is limited by small sample size; for each time point, only one biological specimen was obtained. It is, therefore, plausible that expression differences between time points reflected biological variations (i.e., noise) between individuals rather than tissue-specific variation over time. Differences between tissue types for a given time point could similarly be influenced by individual-specific variation. The small sample size also limits the statistical power to detect differential miRNA expression. While our findings are suitable for hypothesis generation, they should be critically considered on a case-by-case basis, bearing these limitations in mind. Additionally, though we would have liked to validate our findings using secondary methods such as qPCR, these experiments could not be performed due to sample constraints; all available tissue was used to obtain miRNA expression data with adequate quality control from HTG-seq. Many samples yielded only 500–1000 cells upon laser dissection (<xref ref-type="supplementary-material" rid="pone.0191452.s001">S1 Table</xref>). Despite these limitations, many of our findings correlate well with prior findings in the mouse which suggests that they are truly informative about inner ear development in humans. In addition to providing insight into the mechanisms governing the development of the human inner ear, our findings also identify potential signaling pathways for promoting regeneration of human spiral ganglions and other components of the inner ear using pluripotent stem cells in the future.</p>
</sec>
<sec id="sec016">
<title>Supporting information</title>
<supplementary-material id="pone.0191452.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Detailed description of the three FFPE samples.</title>
<p>C-Stage: the Carnegie developmental stage; CR length: Crown-rump length; NC: neural crest; CVG: cochlear-vestibular ganglions; OV: otic vesicle.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s002" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>The quality control chart.</title>
<p>SD: standard deviation. The difference between averaged ANT (control) median normalized counts and the grand mean of the averaged ANT values (Δmean) was computed for each sample and plotted to demonstrate statistical process control for HTG measurement techniques. Samples were deemed acceptable if they fell within ±2SD.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s003" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Boxplots for expression of the top 20 differentially expressed miRNAs over the three time points for CVG, NC, and OV.</title>
<p>Plots of normalized counts versus time for the top 20 differentially expressed miRNAs for each tissue ranked by significance. Error bar = ±2SD, S#1: sample 1; S#2: sample 2; S#3: sample 3.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s004" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Heatmap of differentially activated gene ontological pathways by GSVA analysis (CVG vs. NC).</title>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s005" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Heatmap of differentially activated gene ontological pathways by GSVA analysis (CVG vs. OV).</title>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s006" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Enriched pathways by GSVA analysis.</title>
<p>Comparisons among three tissue types at three time points. Blue bar: biological function; orange bar: molecular function; gray bar: cellular component; and yellow bar: others. The number of pathway is shown inside or next to each bar. S: Stage.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s007" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title>REVIGO treemap of relevance similarity analysis on enriched pathways comparing CVG vs. NC (stage 14).</title>
<p>REVIGO treemap summarizing Gene Ontology biological process categories over-represented in CVG cells compared to NC cells at stage 14. All terms are included with a FDR adjusted <italic>p</italic>-value cutoff at 0.05 from the enrichment analysis. The relevance similarity C-score (uniqueness) cut-off is chosen at 0.7. The size of each rectangle is proportional to the uniqueness for that category. Red circles indicate relevant neuronal development pathways.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s008" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s008" xlink:type="simple">
<label>S1 Dataset</label>
<caption>
<title>Raw expression count data.</title>
<p>Raw expression data for each sample as provided to us by HTG-seq. Raw counts for each sample are converted to counts per million (CPM), then median normalized in the “Normalized” tab. Spiked in brain RNA is used as a control, expecting high correlation between groups. Samples are matched to their normalized data in the “Groupings” tab, then averaged prior to computing fold changes between tissues in the “Fold Change” tab.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s009" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s009" xlink:type="simple">
<label>S2 Dataset</label>
<caption>
<title>Differential expression data across three tissue types.</title>
<p>Differential expression data based analysis with the R Bioconductor limma package. The spreadsheet includes averaged normalized miRNA expression values for each tissue, fold changes for all tissue comparisons, p-values, and false discovery adjusted p-values from limma. Each time point is included as a separate tab.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s010" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s010" xlink:type="simple">
<label>S3 Dataset</label>
<caption>
<title>Differential expression data across three time points.</title>
<p>Differential expression data analyzed using the R Bioconductor timecourse package. The spreadsheet includes averaged normalized miRNA expression values for each time point and the maximum Hotelling T values from the three possible time point comparisons. Results are ordered by rank. Each time point is included as a separate tab.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s011" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s011" xlink:type="simple">
<label>S4 Dataset</label>
<caption>
<title>Differentially targeted genes.</title>
<p>Complete differential gene targeting analysis for each tissue comparison and time point (separate tabs), as analyzed by hypergeometric enrichment. Complete results are included, as well as filtered results for each comparison at the false discovery adjusted <italic>p</italic> &lt; 0.10 level. Genes that contain “transcription factor” in their Gene Ontology are highlighted in light green.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s012" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s012" xlink:type="simple">
<label>S5 Dataset</label>
<caption>
<title>Differentially regulated pathways.</title>
<p>Complete gene set analysis results for each tissue comparison and time point (separate tabs), analyzed using the R Bioconductor mdgsa package. All results are included in each tab.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s013" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s013" xlink:type="simple">
<label>S6 Dataset</label>
<caption>
<title>Complete set of differentially activated gene ontologically activated pathway analysis by GSVA analysis for each tissue comparison.</title>
<p>All results are included in each tab.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s014" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s014" xlink:type="simple">
<label>S7 Dataset</label>
<caption>
<title>Complete set of predicted miR-183 family targeted genes using TargetScanHuman (release 7.1).</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191452.s015" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0191452.s015" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>Materials and methods.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>Authors thank William E. Ditrick (Emily), Marleana Cross, and Cara Crosby (the Woman’s Board of Northwestern Memorial Hospital) for their special guidance towards our funding source; Drs. Miho Tanaka-Matakatsu and Adam Piortowski for their work at the initial phase of this study; and Drs. Maki Motobu and Junko Motobu for an effort to establish a communication channel with our collaborating team at Poznań University.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0191452.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sayed</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Abdellatif</surname> <given-names>M</given-names></name>. <article-title>MicroRNAs in development and disease</article-title>. <source>Physiol Rev</source>. <year>2011</year>;<volume>91</volume>: <fpage>817</fpage>–<lpage>887</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00006.2010" xlink:type="simple">10.1152/physrev.00006.2010</ext-link></comment> MICRORNAS <object-id pub-id-type="pmid">21742789</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shenoy</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Blelloch</surname> <given-names>RH</given-names></name>. <article-title>Regulation of microRNA function in somatic stem cell proliferation and differentiation</article-title>. <source>Nat Rev Mol Cell Biol</source>. Nature Publishing Group; <year>2014</year>;<volume>15</volume>: <fpage>565</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrm3854" xlink:type="simple">10.1038/nrm3854</ext-link></comment> <object-id pub-id-type="pmid">25118717</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weston</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Pierce</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Rocha-Sanchez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Beisel</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Soukup</surname> <given-names>G a</given-names></name>. <article-title>MicroRNA gene expression in the mouse inner ear</article-title>. <source>Brain Res</source>. <year>2006</year>;<volume>1111</volume>: <fpage>95</fpage>–<lpage>104</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.brainres.2006.07.006" xlink:type="simple">10.1016/j.brainres.2006.07.006</ext-link></comment> <object-id pub-id-type="pmid">16904081</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Soukup</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Fritzsch</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pierce</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Weston</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Jahan</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>McManus</surname> <given-names>MT</given-names></name>, <etal>et al</etal>. <article-title>Residual microRNA expression dictates the extent of inner ear development in conditional Dicer knockout mice</article-title>. <source>Dev Biol</source>. Elsevier Inc.; <year>2009</year>;<volume>328</volume>: <fpage>328</fpage>–<lpage>341</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ydbio.2009.01.037" xlink:type="simple">10.1016/j.ydbio.2009.01.037</ext-link></comment> <object-id pub-id-type="pmid">19389351</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedman</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Dror</surname> <given-names>A a</given-names></name>, <name name-style="western"><surname>Avraham</surname> <given-names>KB</given-names></name>. <article-title>Mouse models to study inner ear development and hereditary hearing loss</article-title>. <source>Int J Dev Biol</source>. <year>2007</year>;<volume>51</volume>: <fpage>609</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1387/ijdb.072365lf" xlink:type="simple">10.1387/ijdb.072365lf</ext-link></comment> <object-id pub-id-type="pmid">17891721</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kersigo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jahan</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Pan</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Fritzsch</surname> <given-names>B</given-names></name>. <article-title>The molecular basis of making spiral ganglion neurons and connecting them to hair cells of the organ of Corti</article-title>. <source>Hear Res</source>. Elsevier B.V.; <year>2011</year>;<volume>278</volume>: <fpage>21</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.heares.2011.03.002" xlink:type="simple">10.1016/j.heares.2011.03.002</ext-link></comment> <object-id pub-id-type="pmid">21414397</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kersigo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>D’Angelo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gray</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Soukup</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Fritzsch</surname> <given-names>B</given-names></name>. <article-title>The role of sensory organs and the forebrain for the development of the craniofacial shape as revealed by Foxg1-cre-mediated microRNA loss</article-title>. <source>Genesis</source>. <year>2011</year>;<volume>49</volume>: <fpage>326</fpage>–<lpage>341</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/dvg.20714" xlink:type="simple">10.1002/dvg.20714</ext-link></comment> <object-id pub-id-type="pmid">21225654</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weston</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Pierce</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Jensen-Smith</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Fritzsch</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Rocha-Sanchez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Beisel</surname> <given-names>KW</given-names></name>, <etal>et al</etal>. <article-title>MicroRNA-183 family expression in hair cell development and requirement of microRNAs for hair cell maintenance and survival</article-title>. <source>Dev Dyn</source>. <year>2011</year>;<volume>240</volume>: <fpage>808</fpage>–<lpage>819</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/dvdy.22591" xlink:type="simple">10.1002/dvdy.22591</ext-link></comment> <object-id pub-id-type="pmid">21360794</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mencía</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Modamio-Høybjør</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Redshaw</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Morín</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mayo-Merino</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Olavarrieta</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss</article-title>. <source>Nat Genet</source>. <year>2009</year>;<volume>41</volume>: <fpage>609</fpage>–<lpage>613</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.355" xlink:type="simple">10.1038/ng.355</ext-link></comment> <object-id pub-id-type="pmid">19363479</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lewis</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Quint</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Glazier</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Fuchs</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>De Angelis</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Langford</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice</article-title>. <source>Nat Genet</source>. <year>2009</year>;<volume>41</volume>: <fpage>614</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.369" xlink:type="simple">10.1038/ng.369</ext-link></comment> <object-id pub-id-type="pmid">19363478</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mahmoudian-sani</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Mehri-Ghahfarrokhi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ahmadinejad</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hashemzadeh-Chaleshtori</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Saidijam</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jami</surname> <given-names>MS</given-names></name>. <article-title>MicroRNAs: effective elements in ear-related diseases and hearing loss</article-title>. <source>Eur Arch Oto-Rhino-Laryngology</source>. Springer Berlin Heidelberg; <year>2017</year>;<volume>274</volume>: <fpage>2373</fpage>–<lpage>2380</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00405-017-4470-6" xlink:type="simple">10.1007/s00405-017-4470-6</ext-link></comment> <object-id pub-id-type="pmid">28224282</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davis</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Schwartz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Duchemin</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Carl Barrett</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Post</surname> <given-names>G</given-names></name>. <article-title>Validation of a Multiplexed Gene Signature Assay for Diagnosis of Canine Cancers from Formalin-Fixed Paraffin-Embedded Tissues</article-title>. <source>J Vet Intern Med</source>. <year>2017</year>;<volume>31</volume>: <fpage>854</fpage>–<lpage>863</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jvim.14686" xlink:type="simple">10.1111/jvim.14686</ext-link></comment> <object-id pub-id-type="pmid">28370296</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Xu-Monette</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Jabbar</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Manyam</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Tzankov</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Role of AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma</article-title>. <source>Am J Pathol</source>. American Society for Investigative Pathology; <year>2017</year>; <fpage>1</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajpath.2017.04.009" xlink:type="simple">10.1016/j.ajpath.2017.04.009</ext-link></comment> <object-id pub-id-type="pmid">28627414</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rimsza</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Leblanc</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Unger</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>TP</given-names></name>, <name name-style="western"><surname>Grogan</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Persky</surname> <given-names>DO</given-names></name>, <etal>et al</etal>. <article-title>Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP</article-title>. <source>Blood</source>. <year>2008</year>;<volume>112</volume>: <fpage>3425</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2008-02-137372" xlink:type="simple">10.1182/blood-2008-02-137372</ext-link></comment> <object-id pub-id-type="pmid">18544678</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Zhenqiang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Maddula</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Schwartz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Roberts</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Joshi</surname></name>, <name name-style="western"><surname>Mary-Beth Harpole</surname> <given-names>D</given-names> <suffix>Jr.</suffix></name>, <etal>et al</etal>. <article-title>Non-small cell lung cancer histological sub-typing by gene expression analysis from FFPE tissue</article-title>. <source>American Association for Cancer Research</source>. <year>2014</year>.</mixed-citation></ref>
<ref id="pone.0191452.ref016"><label>16</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Henshaw</surname> <given-names>SK</given-names></name>. <chapter-title>Management of Unintended and Abnormal Pregnancy</chapter-title>. <edition>1st ed.</edition> <name name-style="western"><surname>Maureen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lichtenberg</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Borgatta</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Grimes</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Stubblefield</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Creinin</surname> <given-names>MD</given-names></name>, editors. <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Wiley-Blackwell</publisher-name>; <year>2009</year>.</mixed-citation></ref>
<ref id="pone.0191452.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O’Rahilly</surname> <given-names>R</given-names></name>. <article-title>Developmental stages in human embryos: revised and new measurements</article-title>. <source>Cells Tissues Organs</source>. <year>2010</year>;<volume>192</volume>: <fpage>73</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000289817" xlink:type="simple">10.1159/000289817</ext-link></comment> <object-id pub-id-type="pmid">20185898</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref018"><label>18</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Goodrich</surname> <given-names>L V</given-names></name>. <chapter-title>Early Development of the Spiral Ganglion</chapter-title>. In: <source>The Primary Auditory Neurons of the Mammalian Cochlea, Handbook of Auditory Research 52</source>. <name name-style="western"><surname>Dabdoub</surname> <given-names>A</given-names></name>, editor. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springler Science+Business Media</publisher-name>; <year>2016</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/978-1-4939-3031-9_2" xlink:type="simple">10.1007/978-1-4939-3031-9_2</ext-link></comment></mixed-citation></ref>
<ref id="pone.0191452.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kozomara</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Griffiths-Jones</surname> <given-names>S</given-names></name>. <article-title>MiRBase: Integrating microRNA annotation and deep-sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2011</year>;<volume>39</volume>: <fpage>152</fpage>–<lpage>157</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkq1027" xlink:type="simple">10.1093/nar/gkq1027</ext-link></comment> <object-id pub-id-type="pmid">21037258</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Law</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Smyth</surname> <given-names>GK</given-names></name>. <article-title>voom: precision weights unlock linear model analysis tools for RNA-seq read counts</article-title>. <source>Genome Biol</source>. <year>2014</year>;<volume>15</volume>: <fpage>R29</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/gb-2014-15-2-r29" xlink:type="simple">10.1186/gb-2014-15-2-r29</ext-link></comment> <object-id pub-id-type="pmid">24485249</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dillies</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Rau</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aubert</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hennequet-Antier</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Jeanmougin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Servant</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis</article-title>. <source>Brief Bioinform</source>. <year>2013</year>;<volume>14</volume>: <fpage>671</fpage>–<lpage>683</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bib/bbs046" xlink:type="simple">10.1093/bib/bbs046</ext-link></comment> <object-id pub-id-type="pmid">22988256</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ritchie</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Phipson</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Law</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>;<volume>43</volume>: <fpage>e47</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkv007" xlink:type="simple">10.1093/nar/gkv007</ext-link></comment> <object-id pub-id-type="pmid">25605792</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref023"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Tai Y. timecourse: Statistical Analysis for Developmental Microarray Time Course Data. In: R package version 1.48.0. 2007.</mixed-citation></ref>
<ref id="pone.0191452.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Benjamini</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hochberg</surname> <given-names>Y</given-names></name>. <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J R Stat Soc B</source>. <year>1995</year>;<volume>57</volume>: <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation></ref>
<ref id="pone.0191452.ref025"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2016.</mixed-citation></ref>
<ref id="pone.0191452.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedman</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Farh</surname> <given-names>KKH</given-names></name>, <name name-style="western"><surname>Burge</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Bartel</surname> <given-names>DP</given-names></name>. <article-title>Most mammalian mRNAs are conserved targets of microRNAs</article-title>. <source>Genome Res</source>. <year>2009</year>;<volume>19</volume>: <fpage>92</fpage>–<lpage>105</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.082701.108" xlink:type="simple">10.1101/gr.082701.108</ext-link></comment> <object-id pub-id-type="pmid">18955434</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Durinck</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Spellman</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Birney</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Huber</surname> <given-names>W</given-names></name>. <article-title>Mapping Identifiers for the Integration of Genomic Datasets with the R/Bioconductor package biomaRt</article-title>. <source>Nat Protoc</source>. <year>2009</year>;<volume>4</volume>: <fpage>1184</fpage>–<lpage>1191</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nprot.2009.97" xlink:type="simple">10.1038/nprot.2009.97</ext-link></comment> <object-id pub-id-type="pmid">19617889</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Csardi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nepusz</surname> <given-names>T</given-names></name>. <article-title>The igraph software package for complex network research</article-title>. <source>Inter J</source>. <year>2006</year>;Complex Sy: <fpage>1695</fpage>.</mixed-citation></ref>
<ref id="pone.0191452.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cogswell</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Ward</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>IA</given-names></name>, <name name-style="western"><surname>Waters</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Cannon</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Identification of miRNA Changes in Alzheimer ‘ s Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways</article-title>. <source>J Alzheimer’s Dis</source>. <year>2008</year>;<volume>14</volume>: <fpage>27</fpage>–<lpage>41</lpage>.</mixed-citation></ref>
<ref id="pone.0191452.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herwig</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hardt</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lienhard</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kamburov</surname> <given-names>A</given-names></name>. <article-title>Analyzing and interpreting genome data at the network level with ConsensusPathDB</article-title>. <source>Nat Protoc</source>. <year>2016</year>;<volume>11</volume>: <fpage>1889</fpage>–<lpage>907</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nprot.2016.117" xlink:type="simple">10.1038/nprot.2016.117</ext-link></comment> <object-id pub-id-type="pmid">27606777</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garcia-Garcia</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Panadero</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dopazo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Montaner</surname> <given-names>D</given-names></name>. <article-title>Integrated gene set analysis for microRNA studies</article-title>. <source>Bioinformatics</source>. <year>2016</year>;<volume>32</volume>: <fpage>2809</fpage>–<lpage>2816</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btw334" xlink:type="simple">10.1093/bioinformatics/btw334</ext-link></comment> <object-id pub-id-type="pmid">27324197</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Godard</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Eyll</surname> <given-names>J Van</given-names></name>. <article-title>Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>; <fpage>1</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkv249" xlink:type="simple">10.1093/nar/gkv249</ext-link></comment> <object-id pub-id-type="pmid">25800743</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hänzelmann</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Castelo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Guinney</surname> <given-names>J</given-names></name>. <article-title>GSVA: gene set variation analysis for microarray and RNA-seq data</article-title>. <source>BMC Bioinformatics</source>. <year>2013</year>;<volume>14</volume>: <fpage>7</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-14-7" xlink:type="simple">10.1186/1471-2105-14-7</ext-link></comment> <object-id pub-id-type="pmid">23323831</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mootha</surname> <given-names>VK</given-names></name>, <name name-style="western"><surname>Lindgren</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Eriksson</surname> <given-names>K-F</given-names></name>, <name name-style="western"><surname>Subramanian</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sihag</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lehar</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title>. <source>Nat Genet</source>. <year>2003</year>;<volume>34</volume>: <fpage>267</fpage>–<lpage>273</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng1180" xlink:type="simple">10.1038/ng1180</ext-link></comment> <object-id pub-id-type="pmid">12808457</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Subramanian</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tamayo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mootha</surname> <given-names>VK</given-names></name>, <name name-style="western"><surname>Mukherjee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ebert</surname> <given-names>BL</given-names></name>, <name name-style="western"><surname>Gillette</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci</source>. <year>2005</year>;<volume>102</volume>: <fpage>15545</fpage>–<lpage>15550</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0506580102" xlink:type="simple">10.1073/pnas.0506580102</ext-link></comment> <object-id pub-id-type="pmid">16199517</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref036"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Lin D. An information-theoretic de finition of similarity. Pro- ceedings of the Fifteenth International Conference on Machine Learning (ICML-98). 1998.</mixed-citation></ref>
<ref id="pone.0191452.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlicker</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Domingues</surname> <given-names>FS</given-names></name>, <name name-style="western"><surname>Rahnenführer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lengauer</surname> <given-names>T</given-names></name>. <article-title>A new measure for functional similarity of gene products based on Gene Ontology</article-title>. <source>BMC Bioinformatics</source>. <year>2006</year>;<volume>7</volume>: <fpage>302</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-7-302" xlink:type="simple">10.1186/1471-2105-7-302</ext-link></comment> <object-id pub-id-type="pmid">16776819</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlicker</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Albrecht</surname> <given-names>M</given-names></name>. <article-title>FunSimMat: A comprehensive functional similarity database</article-title>. <source>Nucleic Acids Res</source>. <year>2008</year>;<volume>36</volume>: <fpage>434</fpage>–<lpage>439</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkm806" xlink:type="simple">10.1093/nar/gkm806</ext-link></comment> <object-id pub-id-type="pmid">17932054</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lewis</surname> <given-names>BP</given-names></name>, <name name-style="western"><surname>Burge</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Bartel</surname> <given-names>DP</given-names></name>. <article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>. <source>Cell</source>. <year>2005</year>;<volume>120</volume>: <fpage>15</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2004.12.035" xlink:type="simple">10.1016/j.cell.2004.12.035</ext-link></comment> <object-id pub-id-type="pmid">15652477</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Agarwal</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Bell</surname> <given-names>GW</given-names></name>, <name name-style="western"><surname>Nam</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Bartel</surname> <given-names>DP</given-names></name>. <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source>Elife</source>. <year>2015</year>;<volume>4</volume>: <fpage>1</fpage>–<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.05005" xlink:type="simple">10.7554/eLife.05005</ext-link></comment> <object-id pub-id-type="pmid">26267216</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shearer</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Eppsteiner</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Booth</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>Ephraim</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Gurrola</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Simpson</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Utilizing ethnic-specific differences in minor allele frequency to recategorize reported pathogenic deafness variants</article-title>. <source>Am J Hum Genet</source>. <year>2014</year>;<volume>95</volume>: <fpage>445</fpage>–<lpage>453</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2014.09.001" xlink:type="simple">10.1016/j.ajhg.2014.09.001</ext-link></comment> <object-id pub-id-type="pmid">25262649</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref042"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">The Molecular Otolaryngology and Renal Reseaaarch Laboratories at the University of Iowa. Deafness Variation Database. [Internet]. 2017 [cited 1 Jan 2017]. Available: <ext-link ext-link-type="uri" xlink:href="http://deafnessvariationdatabase.org/" xlink:type="simple">http://deafnessvariationdatabase.org/</ext-link> %0D</mixed-citation></ref>
<ref id="pone.0191452.ref043"><label>43</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Koehler</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Alexander</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Hashino</surname> <given-names>E</given-names></name>. <chapter-title>Recapitulating Inner Ear Development with Pluripotent Stem Cells: Biology and Transition</chapter-title>. In: <name name-style="western"><surname>Raymond</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Varela-Nieto</surname> <given-names>I</given-names></name>, editors. <source>Development of Auditory and Vestibular Systems</source>. <edition>first edit.</edition> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>; <year>2014</year>. pp. <fpage>213</fpage>–<lpage>247</lpage>.</mixed-citation></ref>
<ref id="pone.0191452.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rubel</surname> <given-names>EW</given-names></name>, <name name-style="western"><surname>Fritzsch</surname> <given-names>B</given-names></name>. <article-title>Auditory system development: primary auditory neurons and their targets</article-title>. <source>Annu Rev Neurosci</source>. <year>2002</year>;<volume>25</volume>: <fpage>51</fpage>–<lpage>101</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.neuro.25.112701.142849" xlink:type="simple">10.1146/annurev.neuro.25.112701.142849</ext-link></comment> <object-id pub-id-type="pmid">12052904</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fishilevich</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nudel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Rappaport</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hadar</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Plaschkes</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Iny Stein</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>GeneHancer: genome-wide integration of enhancers and target genes in GeneCards</article-title>. <source>Database</source>. <year>2017</year>;<volume>2017</volume>: <fpage>1665</fpage>–<lpage>1680</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/database/bax028" xlink:type="simple">10.1093/database/bax028</ext-link></comment> <object-id pub-id-type="pmid">28605766</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Supek</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Bošnjak</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Škunca</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Šmuc</surname> <given-names>T</given-names></name>. <article-title>Revigo summarizes and visualizes long lists of gene ontology terms</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0021800" xlink:type="simple">10.1371/journal.pone.0021800</ext-link></comment> <object-id pub-id-type="pmid">21789182</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rudnicki</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Isakov</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Ushakov</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shivatzki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Weiss</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>LM</given-names></name>, <etal>et al</etal>. <article-title>Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways</article-title>. <source>BMC Genomics</source>. <year>2014</year>;<volume>15</volume>: <fpage>484</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2164-15-484" xlink:type="simple">10.1186/1471-2164-15-484</ext-link></comment> <object-id pub-id-type="pmid">24942165</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ushakov</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Rudnicki</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Avraham</surname> <given-names>KB</given-names></name>. <article-title>MicroRNAs in sensorineural diseases of the ear</article-title>. <source>Front Mol Neurosci</source>. <year>2013</year>;<volume>6</volume>: <fpage>52</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnmol.2013.00052" xlink:type="simple">10.3389/fnmol.2013.00052</ext-link></comment> <object-id pub-id-type="pmid">24391537</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rudnicki</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Avraham</surname> <given-names>KB</given-names></name>. <article-title>microRNAs: the art of silencing in the ear</article-title>. <source>EMBO Mol Med</source>. <year>2012</year>;<volume>4</volume>: <fpage>849</fpage>–<lpage>59</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/emmm.201100922" xlink:type="simple">10.1002/emmm.201100922</ext-link></comment> <object-id pub-id-type="pmid">22745034</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bowl</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Dawson</surname> <given-names>SJ</given-names></name>. <article-title>The mouse as a model for age-related hearing loss—A mini-review</article-title>. <source>Gerontology</source>. <year>2015</year>;<volume>61</volume>: <fpage>149</fpage>–<lpage>157</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000368399" xlink:type="simple">10.1159/000368399</ext-link></comment> <object-id pub-id-type="pmid">25471225</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sacheli</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Borgs</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Vandenbosch</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bodson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lefebvre</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Expression patterns of miR-96, miR-182 and miR-183 in the developing inner ear</article-title>. <source>Gene Expr Patterns</source>. Elsevier B.V.; <year>2009</year>;<volume>9</volume>: <fpage>364</fpage>–<lpage>370</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gep.2009.01.003" xlink:type="simple">10.1016/j.gep.2009.01.003</ext-link></comment> <object-id pub-id-type="pmid">19602392</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ivashchenko</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Berillo</surname> <given-names>OA</given-names></name>, <name name-style="western"><surname>Pyrkova</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Niyazova</surname> <given-names>RY</given-names></name>. <article-title>Binding sites of the miR-1273 family, miR-1285-3p and miR-5684 in human mRNAs</article-title>. <source>Recent Adv Biomed Chem Eng Mater Sci</source>. <year>2015</year>; <fpage>102</fpage>–<lpage>107</lpage>.</mixed-citation></ref>
<ref id="pone.0191452.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Grosshans</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Shingara</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Byrom</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jarvis</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>RAS is regulated by the let-7 microRNA family</article-title>. <source>Cell</source>. <year>2005</year>;<volume>120</volume>: <fpage>635</fpage>–<lpage>647</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2005.01.014" xlink:type="simple">10.1016/j.cell.2005.01.014</ext-link></comment> <object-id pub-id-type="pmid">15766527</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname> <given-names>YM</given-names></name>, <name name-style="western"><surname>Peng</surname> <given-names>HX</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>FL</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title><italic>MicroRNA-1254</italic> inhibits the migration of colon adenocarcinoma cells by targeting <italic>PSMD10</italic></article-title>. <source>J Dig Dis</source>. <year>2017</year>;<volume>18</volume>: <fpage>169</fpage>–<lpage>178</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1751-2980.12463" xlink:type="simple">10.1111/1751-2980.12463</ext-link></comment> <object-id pub-id-type="pmid">28296190</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lassiter</surname> <given-names>RNT</given-names></name>, <name name-style="western"><surname>Stark</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>C</given-names></name>. <article-title>Signaling mechanisms controlling cranial placode neurogenesis and delamination</article-title>. <source>Dev Biol</source>. <year>2014</year>;<volume>389</volume>: <fpage>39</fpage>–<lpage>49</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ydbio.2013.11.025" xlink:type="simple">10.1016/j.ydbio.2013.11.025</ext-link></comment> <object-id pub-id-type="pmid">24315854</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyers</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Kessler</surname> <given-names>JA</given-names></name>. <article-title>TGF- b Family Signaling in Neural and and Function</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2017</year>; <fpage>1</fpage>–<lpage>26</lpage>.</mixed-citation></ref>
<ref id="pone.0191452.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuoka</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Morrissey</surname> <given-names>ZD</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Homma</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Belmadani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>CA</given-names></name>, <etal>et al</etal>. <article-title>Directed differentiation of human embryonic stem cells toward placode-derived spiral ganglion-like sensory neurons</article-title>. <source>Stem Cells Transl Med</source>. <year>2017</year>;<volume>6</volume>: <fpage>923</fpage>–<lpage>936</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/sctm.16-0032" xlink:type="simple">10.1002/sctm.16-0032</ext-link></comment> <object-id pub-id-type="pmid">28186679</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van den Ackerveken</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mounier</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Huyghe</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sacheli</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Vanlerberghe</surname> <given-names>P-B</given-names></name>, <name name-style="western"><surname>Volvert</surname> <given-names>M-L</given-names></name>, <etal>et al</etal>. <article-title>The miR-183/ItgA3 axis is a key regulator of prosensory area during early inner ear development</article-title>. <source>Cell Death Differ</source>. <year>2017</year>; <fpage>2054</fpage>–<lpage>2065</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cdd.2017.127" xlink:type="simple">10.1038/cdd.2017.127</ext-link></comment> <object-id pub-id-type="pmid">28777373</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>León</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sanz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Frago</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Camarero</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Cañón</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Varela-Nieto</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Involvement of insulin-like growth factor-I in inner ear organogenesis and regeneration</article-title>. <source>Horm Metab Res</source>. <year>1999</year>;<volume>31</volume>: <fpage>126</fpage>–<lpage>132</lpage>. <object-id pub-id-type="pmid">10226792</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Camarero</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Avendano</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fernandez-Moreno</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Villar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Contreras</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>de Pablo</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice</article-title>. <source>J Neurosci</source>. <year>2001</year>;<volume>21</volume>: <fpage>7630</fpage>–<lpage>7641</lpage>. <object-id pub-id-type="pmid">11567053</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Linker</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Stern</surname> <given-names>CD</given-names></name>. <article-title>Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists</article-title>. <source>Development</source>. <year>2004</year>;<volume>131</volume>: <fpage>5671</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.01445" xlink:type="simple">10.1242/dev.01445</ext-link></comment> <object-id pub-id-type="pmid">15509767</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>XR</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XM</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>H</given-names></name>. <article-title>MicroRNA-182 regulates otocyst-derived cell differentiation and targets T-box1 gene</article-title>. <source>Hear Res</source>. Elsevier B.V.; <year>2012</year>;<volume>286</volume>: <fpage>55</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.heares.2012.02.005" xlink:type="simple">10.1016/j.heares.2012.02.005</ext-link></comment> <object-id pub-id-type="pmid">22381690</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vitelli</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Viola</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Morishima</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pramparo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Baldini</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lindsay</surname> <given-names>E</given-names></name>. <article-title>TBX1 is required for inner ear morphogenesis</article-title>. <source>Hum Mol Genet</source>. <year>2003</year>;<volume>12</volume>: <fpage>2041</fpage>–<lpage>2048</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddg216" xlink:type="simple">10.1093/hmg/ddg216</ext-link></comment> <object-id pub-id-type="pmid">12913075</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reyes</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>LeBlanc</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Bassila</surname> <given-names>MK</given-names></name>. <article-title>Hearing loss and otitis media in velo-cardio-facial syndrome</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. <year>1999</year>;<volume>47</volume>: <fpage>227</fpage>–<lpage>233</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0165-5876(98)00180-3" xlink:type="simple">10.1016/S0165-5876(98)00180-3</ext-link></comment> <object-id pub-id-type="pmid">10321777</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Digilio</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Pacifico</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tieri</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Marino</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Giannotti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dallapiccola</surname> <given-names>B</given-names></name>. <article-title>Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome)</article-title>. <source>Br J Audiol</source>. <year>1999</year>;<volume>33</volume>: <fpage>329</fpage>–<lpage>333</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/03005369909090116" xlink:type="simple">10.3109/03005369909090116</ext-link></comment> <object-id pub-id-type="pmid">10890147</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eynde</surname> <given-names>C Van</given-names></name>, <name name-style="western"><surname>Swillen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lambeens</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Verhaert</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Desloovere</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Luts</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Prevalence and Nature of Hearing Loss in 22q11.2 Deletion Syndrome</article-title>. <source>J Speech, Lang Hear Res</source>. <year>2016</year>;<volume>59</volume>: <fpage>583</fpage>–<lpage>589</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1044/2015_JSLHR-H-15-0098" xlink:type="simple">10.1044/2015_JSLHR-H-15-0098</ext-link></comment> <object-id pub-id-type="pmid">27249537</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antoine</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Vijayakumar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>McKeehan</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Hébert</surname> <given-names>JM</given-names></name>. <article-title>The Severity of Vestibular Dysfunction in Deafness as a Determinant of Comorbid Hyperactivity or Anxiety</article-title>. <source>J Neurosci</source>. <year>2017</year>;<volume>37</volume>: <fpage>5144</fpage>–<lpage>5154</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1523/JNEUROSCI.3545-16.2017" xlink:type="simple">10.1523/JNEUROSCI.3545-16.2017</ext-link></comment> <object-id pub-id-type="pmid">28438970</object-id></mixed-citation></ref>
<ref id="pone.0191452.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swillen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Devriendt</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Legius</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Prinzie</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Vogels</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ghesquière</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence</article-title>. <source>Genet Couns</source>. <year>1999</year>;<volume>10</volume>: <fpage>79</fpage>–<lpage>88</lpage>. <object-id pub-id-type="pmid">10191433</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>